Louisiana Tech University

Louisiana Tech Digital Commons
Doctoral Dissertations

Graduate School

Spring 2011

Manipulating cellular growth responses to
patterning, apoptotic, and environmental cues
James N. McNamara

Follow this and additional works at: https://digitalcommons.latech.edu/dissertations
Part of the Biomedical Engineering and Bioengineering Commons

MANIPULATING CELLULAR GROWTH
RESPONSES TO
PATTERNING, APOPTOTIC, AND
ENVIRONMENTAL CUES
by
James N. McNamara, B.S.

A Dissertation Presented in Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy

COLLEGE OF ENGINEERING AND SCIENCE
LOUISIANA TECH UNIVERSITY

May 2011

UMI Number: 3459548

All rights reserved
INFORMATION TO ALL USERS
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.

UMI
Dissertation Publishing

UMI 3459548
Copyright 2011 by ProQuest LLC.
All rights reserved. This edition of the work is protected against
unauthorized copying under Title 17, United States Code.

ProQuest LLC
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor, Ml 48106-1346

LOUISIANA TECH UNIVERSITY
THE GRADUATE SCHOOL
13 April 2011
Date

We
by_

hereby

recommend

that

the

dissertation

prepared

under

our

supervision

James N. McNamara

entitled

Manipulating Cellular Growth Responses to Patterning, Apoptotic,
and Environmental Cues

be

accepted

in

partial

fulfillment

of

the

A

requirements

for

the

Degree

of

7S4^-~/Supen/isor of Dissertation Research
Head of Department
Department

Recommendation concurred in

Advisory Committee

Hxmg, SUauz-^xC
Approved:

Approved:

Krector of Graduate Studies

2ft.

Dean of the Cofiege
GSForm 13a
(6/07)

ABSTRACT
In this work, various methods of controlling cell growth are examined. Cell-cell
interaction, apoptotic cues, three dimensional scaffolds, and non-adherent environments
are evaluated for their ability to affect the differentiation, morphology, and growth rate of
different cell types. Previous work has shown that cell growth and cell morphology can
be influenced by patterns of polymers coated on surfaces in two dimensions, designated
here as the x and y dimensions of a standard Cartesian coordinate system. Tissue
engineering and regenerative medicine studies have shown limited success in modifying
growth in the third, z dimension. This work considers not only the x, y, and z dimensions,
but also the fourth dimension, time. The time dimension is explored via apoptosis. The x
and y dimensions are inspected through surface patterning, and the three physical
dimensions are scrutinized together by means of scaffolding-cultured cells and
cytophobic surfaces for non-adherent aspects of cell patterning. The project goals
accomplished here are: (1) to develop a simple model of apoptosis that can be used to
determine visually the temporal progression of apoptosis and to determine whether
staurosporine-induced apoptosis can be delayed by pre-treatment of cells with glutamate ,
(2) to determine the viability of a cellulose/gelatin biologically-derived 3D cellular
scaffolding construct as a platform for tissue engineering, (3) to develop a novel celladherence blocking strategy that will improve the localization of cell adherence to
patterns deposited by the NanoEnabler® system.

iii

iv
Measures of apoptotic activity based on digital images showing changes in cell
area, cell shape, nuclear area and nuclear shape were used to develop the Cell Area
Factor and Nuclear Area Factor model. Biochemical assays for mitochondrial activity and
for caspase 3 (casp3) activity showed a delay in staurosporine induced apoptosis. Digital
images of the scaffold materials demonstrated the scaffold's ability to encourage cell
invasion, growth and differentiation. The image observations were supported by MTT
assays showing increased metabolic activity of the cells indicating proliferative culture.
The adherence blocking strategy discussed resulted in 3D growth of cancerous brain
tumor cells tracked via digital imaging and tumor area analysis. Calcein vital dye staining
supported the evidence for a growing tumor colony.
The three approaches for cell growth modification, apoptotic stimuli, scaffolding
directional cues, and negative adhesive cues (cytophobic surfaces), are considered as
building blocks that can be combined in a broader tissue engineering strategy to control
the adhesion, morphology, and differentiation of cells. The apoptotic modulator
chronicled in this work can be used to modify biological pathways in vitro and provide a
more biomimetic environment that can be used to engineer tissues and to formulate and
test new experimental hypotheses. The success of the biologically derived
cellulose/gelatin material indicates that further work is warranted to develop it as a
scaffold to support and cultivate 3D engineered, spatially defined tissues. The cytophobic
surface has lead not only to a new blocking strategy, but also to the unexpected result of
leading to a novel 3D model of cancer progression in vitro that closely resembles the in
vivo situation.
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CHAPTER 1
INTRODUCTION
1.1 Overview of Cells and Biology
1.1.1 Cells
Cells are the most basic unit of life, according to Schleiden and Schwann, circa 1839
[/]. In the 1700s, the microscopist Anton von Leeuwenhoek called the single celled
organisms he found "animalcules," and it took almost one hundred years to get to
Schleiden and Schwann's cell theory from there. The term "cell" is still in use, and the
theory, though evolved somewhat, stands, even today. As knowledge advances, ever
more is found about the amazing diversity and similarities that cells display. The word
"cell" comes from the Latin cella meaning small room, and was used first by Robert
Hooke. In his 1655 tome Micrographia [2], Hooke called them cells, and the name stuck.
Hooke is also known for his work in physics, with "Hooke's Law" being taught in all
current physics classes.
Humans are multi-cellular organisms, with many specialized groups of cells that
function in specific capacities. Groups of cells with similar functions are known as
tissues. Groups of tissues form organs, and organs form systems. As humans age, tissues,
organs and systems become less and less effective at their specific tasks, leading to
symptoms such as dementia, decreased mobility, increased blood pressure, and gray hair,
among other things. As humans, aging and injury require medical treatments to restore
lost functionality, and enhance the quality of life, especially as the current level of
1

2

healthcare brings longer life spans. As technology advances, there come more complex
treatment strategies, in an effort to address the issue of aged, diseased, or traumatized
tissues and organs. These scenarios require treatments with increasingly narrow
specificities that may be administered to genetically specific individuals, meaning some
treatments such as cartilage tissue replacement involves external growth of the patient's
own tissue. This reduces immunological factors for tissue transplant, but these
increasingly stringent requirements bring us to the idea of growing tissues and even entire
organs or tissue structures as direct replacements for damaged or diseased tissue. There
have been attempts at mammalian tissue culture since the 1870s, when the French
physiologist Claude Bernard outlined the concept that the tissue environment is
somewhat of a function of the tissue's own metabolic processes, and that these processes
shape the environment, then the environment shapes the tissue in reciprocity [3]. Tissue
growth must be controlled at the cellular level.

1.1.2 Why Pattern Cells?
This project of manipulating surfaces and morphology responds to a basic need in
many disciplines for controlled cell growth. Applications exist in such fields as tissue
engineering, cell-based drug screening, cell-based drug delivery for new drugs, and basic
biological studies of cell-cell interactions and morphology [4], [5], [6]. Using varied
techniques to achieve patterning of the different cell types leads to many procedures, all
with similar goals.
All of these methods fall under the field of regenerative medicine. Regenerative
medicine is defined by the National Institutes of Health (NIH) as "the process of creating
living functional tissue to repair or replace tissue or organ function lost due to age,

disease, damage, or congenital defects" [7]. The aforementioned goals toward cellular
control, apply to a large pool of research that is growing larger every day. The NIH states
approximately 500,000 transplants are performed per year, in United States alone, while
as of 2010, 108,000 people were waiting for organ donors [7]. All of the research being
done now on the cellular level will not be able to help those 108,000 people, but may one
day eliminate the waiting list, as technology builds further on the cellular level to create
whole organs in precisely defined, three dimensional (3D) structures. And they must all
start from individual cells, at the level which is now being explored.
1.2 Financial Justification for Targeting Controlled Cell
Growth Patterns
1.2.1 Nervous System Injuries
The hierarchical organization of life is defined as cells forming tissues, tissues
forming organs, organs forming systems, systems forming an organism. The existent
tissue and organ structures that wear out due to every day human life, or are injured from
our many endeavors, form the basis of our designs to regenerate tissues, and even organs.
With age, or injury, the result is often tissue damage that does not heal to a functionally
equivalent set- point in comparison to the younger or undamaged tissue. This incomplete
or ineffective healing is the starting point for our goals of manipulating cell growth. After
many injuries, such as to the spine, the results of tissue damage can be debilitating. The
National Spinal Cord Injury Association states that there are approximately eight
thousand new spinal cord injuries per year in the U.S. This is a small percentage of the
total population of over three hundred million in the U.S. Obviously, these are costly
injuries [8]. These costs can be upwards of three million dollars per individual, as shown
by the National Spinal Cord Injury Statistical Center in Birmingham, Alabama [9]. These
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are health care costs that can possibly be done away with, assuming the advent of a tissue
regeneration paradigm allowing engineered tissue to repair or replace
injured/damaged/aged tissue.
Spinal cord injury is only a small part of the regenerative medicine picture. Two
other important pathologies are traumatic brain injuries and, degenerative diseases such
as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. These are all
targets for biomedical engineering solutions that could involve patterned cell response.
Again, finances should not be an issue when one begins to calculate the costs associated
with not repairing these disorders.
1.2.2 Cancer and Cell Patterning
Turning attention to cancer, one would recognize immediately that cancer is an
obvious target for research, but not so obvious a target for patterned cells. The current
project aims at two dimensional patterning (2D), the x and y planes. Growing cancer cells
in 2D and testing drugs and delivery systems on said culture is the current "state of the
art." With the recent advent of 3D culture systems, cancer cells could be grown in an
environment more similar to the in vivo environment. This would lead to more effective
initial trials, and possibly cull the less effective drugs prior to animal or pre-clinical
studies [10]. Taking this 3D culture further, and patterning the matrix to mimic the
extracellular matrix would give an unprecedented level of parity to in vivo
experimentation. These 3D efforts are relatively new, but show great promise in
mimicking the intercellular milieu to successfully pattern cells as they would be found in
their native tissue formations [11]. By engineering tumors that occur and progress more
like the in vivo counterparts, as will be seen later in this research, cancer research would
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advanced, giving new perspective with in vitro models that allow more accuracy when
modeling the in vivo scenario. The National Cancer Institute alone spends approximately
five billion dollars per year on research and treatment development [12], illustrating the
financial imperative for furthering cancer research.
1.3 Theoretical Basis for Cell Patterning
1.3.1 Cell Culture in the Laboratory
This document has already covered, albeit incompletely, some of the logic used in
choosing to pursue patterned cell cultures. The goals have been set, by the scientific
community at large, to regenerate damaged or diseased tissue, and improve the quality of
life for many. This line of research begs the question "how can cells be coaxed grow in
three dimensions, as they do during the developmental stages?" As stated earlier, there
have been attempts at mammalian tissue culture since the 1870s, when the French
physiologist Claude Bernard outlined the concept that the tissue environment is
somewhat a function of the tissue's own metabolic processes, and as these processes
shape the environment, the environment then shapes the tissue [3]. He also stated that for
proper determination of tissue properties, the tissue must be grown in an artificial system.
This sparked the use of primary cell culture, cells taken directly from a living animal,
well over one hundred years ago. Scientists have been trying to grow tissue that matches
native tissue ever since. The first simple cultures were problematic, due to the limitations
of aseptic technique; rendering the idea that tissue culture was an intricate, complex
endeavor.
By 1912, the technology to grow tissue outside the body had reached a new
height. Dr. Alexis Carrel, a French surgeon, cultured chic embryo heart muscle cells in a
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flask, and was able to observe them pulsating [13]. This captured the imagination of the
scientific community, and Dr. Carrel proposed the cells could live indefinitely. The flask
remained active for 20 years, but no one was ever able to reproduce the experiment. In
1961, Leonard Hayflick published a limitation of cultured cells at about 50 sub
cultivations, or about one year in culture. This is known today as the Hayflick limit, and
is often cited as the current limit today, although the DeCoster lab uses even more
stringent passaging guidelines [14].
1.3.2 Cell Culture Surfaces
All laboratory work was carried out in glass, at one time. Petri dishes of various
sizes, flasks of different shapes-serving varied purposes-and other lab ware are all
created from glass. Glass has the correct optical properties, and it is conducive to
microscopy. The drawbacks were washing requirements, often acid wash followed by
base washes to rid the surface of protein deposits, and one had to be quite careful not to
scratch the growth surface [15]. Glass has worked for most cell culture needs, as the
hydrophilic surface seems to carry the correct charge for cell attachment, but due to the
drawbacks, some looked for easier methods with disposable lab ware [15].
Polystyrene is a clear polymer used in CD and DVD cases, insulation, and
inexpensive, disposable coolers at the grocery store. It is a clear polymer that has been
used extensively in disposable lab ware. It is highly hydrophobic [16], which is perfect
for non-adherent cultures. For tissues that require adherence for differentiation and
reproduction, there needs to be a treatment of the surface. Typical treatments include
protein adsorption or adsorption of amino acids such as poly L-Lysine. Indeed, poly-LLysine, the polymeric version of the amino acid Lysine, is the standard treatment to
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increase adhesion [17]. Meanwhile, many companies offer treated polystyrene, alongside
untreated for adherent and non-adherent cell growth respectively. These treated
polystyrene culture vessels use a variety of biological coatings, such as extracellular
matrix (ECM), collagen, laminin, or polysaccharides found in the ECM [18]. Chemical
methods can be used to modify a surface. For example, treatment with sulfuric acid
produces a surface layer with many hydroxyl groups, which increases wettability, and
adhesion for many cell lines [19], [20]. These various coatings and treatments make
polystyrene lab ware quite suitable for most tissue culture activities, and very popular.
Dishes for experimentation made of poly styrene, are available coated and uncoated, and
are similar to those seen in Figure 1.
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Figure 1. Polystyrene dishes available from the Sarstedt
company [15].
Many other types of polystyrene and glass, dishes, slides, and flasks, are available
commercially. These disposables can be helpful in the lab, and are the standard lab ware
at this time, but the other surfaces are of interest, especially to neuroscientists. Silicon,
the material of computer chips, and a percentage of most glasses, is also desirable for
growth of cells, as silicon can be machined with great precision. Because gold surfaces
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are inert and highly conductive, there is much interest in coaxing cells to grow on gold.
As seen in Figure 2, cells can be grown on a nanometers thin layer of gold sputtered onto
a glass cover slip. The functional applications here include biosensors and biological
"chips" with embedded circuitry [21].

Figure 2. CRL2020 human carcinoma cells on gold
sputtered glass cover slips.
Other metals, such as titanium, are of great interest to tissue engineers in the
context of joint replacement. These surfaces will be reviewed in the literature review
portion, but the focus of this project is on glass and polystyrene.
1.4 Project Overview
1.4.1 Three Tiered Approach to Controlling Cellular
Growth
This project examines cellular patterning from three distinct conceptual
perspectives: (1) use of the cellular process of apoptosis as a prompt for directing cellular
architecture (i.e. glutamate modulating staurosporine induced apoptosis), (2) use of
cellulose materials to act as scaffolding material which encourages cell invasion, growth
and differentiation, thereby affecting cell patterns of growth, rate of growth and
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differentiation of the cells in culture, and (3) use of cytophobic, or negative adhesive cues
to increase the fidelity of patterned cells in culture by preventing local adhesion to
surfaces, thus controlling pattern and cell shape, while possibly affecting differentiation.
1.4.2 General Hypothesis
The project was conceived based on the hypothesis that cellular mechanisms
govern adhesion, growth, and differentiation could be controlled by specifically
engineered surfaces and environs for cells in culture.
1.4.3 Experimental Hypotheses
The first portion of the project presents measurements of apoptosis-induced
cellular changes and tests the hypothesis that staurosporine-induced apoptosis can be
delayed by treatment of the cells with glutamate.
The second portion of the project was conducted to determine whether cellulosic
fibers could be a suitable biologically derived cell culture scaffold to be used as a tissue
engineering construct. Specifically, the experiments tested the hypothesis that
cellulose/gelatin would support cell growth, allow penetration of the cells, and alter cell
morphology.
The third portion of the project postulates a quantifiably better strategy for
blocking non-specific binding of cells than the current method of using bovine serum
albumin. The tested hypothesis was that cell growth could be locally prevented by a
cytophobic surface treatment.

CHAPTER 2
BACKGROUND AND LITERATURE
REVIEW
2.1 Common Patterning Methods and Goals
2.1.1 Introduction to Patterning Methods
There are many common methods for modifying our chosen surfaces. Current and
past literature will be reviewed here that details various strategies for chemical
modification of glass and polystyrene, along with mechanical methods, such as
micromachining of the surface. The chemical approach, starting with bulk surface
modification, and proceeding through multi-step, complex procedures for achieving
patterns that guide and coax various cell types to grow will be discussed.
Lithographic methods use lasers with various masks and steps to add and remove
layers of chemicals. These procedures are complex, and require a great deal of time to
manufacture, making them less attractive as technology marches forward.
Variations of the chemical modification method use stamps manufactured from
polymers or use special machines to apply small amounts of chemicals to the chosen
surfaces to achieve either an adhesive, or a non-adhesive area for the cells, are also used.
These methods are all useful in their way, and as the reader will find, by drawing on a
broad knowledge base of patterning techniques, one may choose a method or methods
that best suit the situation and accommodations available. Many researchers choose
methods that dovetail with each other, or they manipulate the methods to create a
10
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completely different protocol by designing the steps of the protocol in an order that suits
their particular purpose.
2.1.1.1 Lithography
Lithography, as defined by the Merriam-Webster dictionary has two meanings.
The first is "the process of printing from a plane surface (as a smooth stone or metal
plate) on which the image to be printed is ink-receptive, and the blank area ink-repellent."
The other definition is "the process of producing patterns on semiconductor crystals for
use as integrated circuits." The latter definition is the one which is addressed here.
Semiconductors such as silicon are of great interest in patterning of cells. Patterning cells
on the silicon after fabricating electrodes or other devices, fabricated from glass (or other
silicon based substrates) would be of great interest [22], [23], [24].
The "critical feature size" is the smallest feature of the pattern that is desired.
With this feature in mind, one chooses the substrate and coating for said substrate. The
procedure for micromachining often uses photosensitive chemicals to make the patterns,
called photo resist, or more simply, resist. This is the basis of optical lithography, using
resist that is sensitive to light in the optical spectrum of wavelengths. This resist is
usually a liquid, of varying viscosities, dependent upon the chosen application and feature
size. The resist applied to circular silicon wafers, using a machine of precision design
called the spin-coater. The spin-coater uses precision rotation speeds to achieve specific
surface thicknesses of resist, based on manufacturer stated viscosity. There are frequently
tables supplied with the resist from the manufacturer, providing information pertaining to
the quantity of resist to use, rate, and duration of the spin coating. Once the resist is
coated on the wafer, there may be further processing, such as heating. These steps are
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again based on the type of resist and thickness of the layer, which may be as small as 130
nanometers thick [25].
With the pattern in mind, and resist chosen, the wafer must be prepped for
coating. They preparation method is usually cleaning with isopropyl alcohol and acetone,
then baking it to remove any water. The wafer is then coated with resist, and heated to
cure the resist.
Next a photo mask is applied. The mask is basically a blocking agent, such as an
adhesive plastic, that may be patterned in the design of the device or cell pattern that is
desired. This pattern is cut out of the plastic by complex plotting software, on a special
printer. With the desired features cut into the mask, it is then applied to the wafer. Once
the mask is in place, the wafer is exposed. Once exposed, the resist polymerizes and
changes characteristics. After exposure, the wafer is put into a developer solution, and
depending upon the solution used, the exposed portion or the unexposed portion may be
washed away. As in Figure 3, the exposed portion is washed away.

Figure 3. Example of negative lithographic patterning.
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While there is no problem with developer and cleaning solutions for electronic
devices, the combination of electronic devices and cell culture require different standards
of chemistry.
The overall schematic for the process is shown in Figure 4, which has been
excerpted from MEMSnet [26].
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Figure 4. Lithography schematic [26].
Other methods of lithography, the so-called "soft lithography" of dip pen methods
and similar methods of deposition of various reagents are also employed [27], [28], [29],
[30].
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2.1.1.2 Chemical Methods of Surf ace Modification for
Adhesion
Many of these methods of chemical modification are the basis for further linking
of adherent molecules to a glass surface. Glass is a hydrophilic surface, owing to its many
hydroxyl surface groups [16]. The surface chemistry of glass is such that it is suitable for
many types of cells to grow on, allowing for protein adsorption to which the cells can
then anchor [31]. Many cell lines have an affinity for growth on glass, and not other
surfaces. This affinity is the impetus for chemical treatments and surface modification, as
many lines adhere, while many lines and types do not, or their morphology is
quantitatively different when using an untreated surface.
One of the most common methods of surface modification is the coating with
poly-L-lysine. This is a synthetic polymer of lysine, an essential amino acid that has basic
properties, and carries a net positive charge at physiologic pH. The lysine molecule is
shown in Figure 5.

«$=> epsilon amine gioup

alpha carboxjl group

alpha amine group

Figure 5. Amino acid lysine.
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The Lysine molecule above shows the different active sites of the amino acid, and
these are important when discussing the differences between poly-L-lysine and peptides.
The poly-1-Lysine polymer differs from a peptide. Peptides, and longer strands of
peptides called proteins are formed from polymerization as well, but the reaction is the
condensation of the alpha (a) amino of one moiety combining with the alpha (a) carboxyl
of another moiety. The result is a covalent bond between the a-nitrogen and the acarboxyl carbon. Poly-L-lysine uses the amine group on the end of the amino side chain,
the epsilon (E) amine group for polymerization with the a-carboxyl group, creating
slightly different chemistries than a peptide bond. These differences owe to the relative
distance of the £-amine from the a-carboxyl group. The relative proximity of the a-amine
yields a peptide bond that shows polarity of a partial double bond, stabilizing the
structure. It is this particular trait that gives rise to the secondary structures of proteins,
such as a-helices, when the dipole moments align. The main difference, the so called sbond for the condensation, yields a polymer with monomers as shown in Figure 6.

Figure 6. Illustration of £-bonded lysine residues.
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As seen previously, the poly-L-lysine with the e-amide bond has a compact
structure, with amine groups carrying a slightly positive charge alternating along the
backbone. A poly-lysine peptide would look like Figure 7.

NH
Amide Bond
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O
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Figure 7. Peptide bonded lysine residues.
The two figures illustrate clearly the difference between the different types of
"poly-L-lysine," synthetic polymer, and peptide form. When discussing poly-L-lysine
throughout the rest of this work, the synthetic polymer form will be the implied meaning
unless otherwise stated. This small point is important though, as the cell membrane that
encompasses the cell is composed of a phospholipid bilayer. This phosphate-ion-based
molecular layer has the "polar head," the phosphate group, situated on the inside and the
outside of the membrane, as seen in Figure 8. This highly negatively charged
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Figure 8. Phospholipid structure.
phosphate group has a great affinity for the positively charged polycation PLL. Of
course, the inclusion of proteins in the membrane, such as receptors and transporters may
drastically change the membrane net charge, but this is the basis for the attraction for
most cells.
The next method of chemical surface modification that is common for lab ware is
silane treatment [32]. Borosilicate glass is the most common type of glassware found in
the laboratory, and the trade name for this is Pyrex® [33], [34], which is often used in
cell culture. Using silane, the reduced form of the silicon molecule, is common for
patterning [35]. The silicon molecule with four hydrogen molecules bound to it, shown in
Figure 9, is the basis for the many silane derivatives used for surface coating.
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Figure 9. Silane molecule
Silane treatments can be aqueous, organically solvated, or applied by vapor
deposition [36], [37], [38], [39]. Some of these methods require heat, some acid bath
treatment prior to the application of the silane treatment, and some require even harsher
chemistries to etch the surface of the glass to expose more of the hydroxyl groups present
in the glass. Alkoxy- derivatives of silane are also used, as the oxidized form of the silane
can bind covalently to the surface of the glass [40]. Glass surfaces display hydroxyl (OH)
groups that are the sites of adsorption [41], [42], and the sites of interaction with
siloxanes such as 3-aminopropyltriethoxysilane (APTES) [43], as shown in Figure 10.
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Figure 10. 3-aminopropyltriethoxysilane [43].
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When the compound is applied, the result is a coordinated bond between the
silane oxygen groups and the surface. This orientation then leaves a monolayer [32], [39]
of the silanes bound covalently to the glass surface, with an active amine group tethered
to the surface. This group is used to react with proteins for immobilization on top of the
polymer layer. The cartoon, illustrating the functional groups left on the surface, is shown
in Figure 11.

Figure 11. Cartoon illustrating APTES coordination with
glass surface.
This bond can then be heat cured, and is not easily broken. Before heat curing the
silane layer can be easily hydrolyzed by rinsing with water. After curing the bond is
permanent, and allows easy protein immobilization by reacting with the free amine group
shown circled in red. Once the proteins are on the surface, they then become covalently
bound [44].
This APTES method is a variation that isfrequentlyused, but there are other
silane compounds available. APTES, as a coating itself makes the surface of glass
hydrophobic [44], but the presence of the amine group allows for protein binding, and
cell adhesion. The so-called chlorosilanes, and fluorosilanes, are used to create highly
hydrophobic surfaces that do not allow cell attachment or protein adsorption [45], [46].
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This allows us to choose either adhesive or non-adhesive surface coatings, and using the
chemistry of the end group of the silane to then bind selective adherent proteins or
polymers to the silane coating, giving a true bottom-up nanofabrication method for
cellular patterning [47].
Another method of chemical modification to cell culture surfaces is the
"engineered polyelectrolyte layering" approach [48]. Surfaces are modified en masse by
the addition of alternating charge polyelectrolyte layers. This approach is called the
"Layer by Layer" method by many or just LbL [23], [49], [50]. This method uses the
attraction of oppositely charged poly ions to create surface coatings with Angstrom level
resolution [50], and is really quite simple to achieve.
With a chosen substrate, determining the surface charge is the first step. Next, one
would choose a poly ion, such as polystyrene sulfonate (PSS), as in Figure 12, if the
surface has a positive charge. In the case of glass, the accepted beginning layer
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Figure 12. Polystyrene sulfonate ionic molecule [51].
would be a polycation such as polyallylamine hydrochloride (PAH), shown in Figure 13,
to complement the surface charge of the target substrate.
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Figure 13. Poly allylamine [51].
By immersing the substrate in a solution of the polymer, it will automatically
assemble a monolayer. Since the polymer still carries its charge, after washing, the
substrate with oppositely charged layer is then immersed in a solution of a polyelectrolyte
with the same charge as the substrate surface. This arranges a layer of that polymer on
top of the previous level. The process is repeated, and various poly ions are able to be
included. There are also modifications used to trap proteins between the layers [23], [52].
Dr. Yuri Lvov, here at Louisiana Tech University has shown that enzymes layered onto
surfaces in this manner retain their catalytic activity, and has demonstrated such [53],
with schematic shown in Figure 14, excerpted from that work.

Figure 14. Layer-by-layer schematic [53].
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To prove these layers do indeed exist, as they are unable to be seen without the
use of electron microscopy, mass buildup is measured. In order to measure mass buildup,
the quartz crystal microbalance (QCM) is employed. This machine uses a quartz crystal
and gold electrodes on each side of the thin crystal. The unit is attached to a high
frequency resonator, and the changes in the crystal resonance can be used to calculate the
amount of mass deposited on the electrodes [54]. An example of a QCM electrode setup
is shown in Figure 15. As the layers are deposited, the frequency shifts lower, and the

metal electrodes on
the opposite sides

quartz
plate
Tfcy wire holders
contacts

Figure 15. QCM crystal [54].
change from layer to layer is then used to calculate the mass of substance in the layer.
With the addition of measuring the surface charge via zeta potential, the supporting
nature of both measurements reveals successful layering.
These approaches also yield great flexibility when designing experiments. By
choosing the molecules or poly ions carefully, one can simultaneously influence binding
and morphology of the target cells, using one or many of these techniques.
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2.1.1.3 Surface Machining
Surface modification at a structural level, by removing surface material is the
focus of this section. This aspect of controlling cell growth and morphology is not a large
part of the current work, but will be addressed here toward a more complete
understanding of the available technologies.
Laser ablation is a method for making micron and sub micron level patterns in
various materials. Using a UV wavelength laser, and short, defined pulses, reports show
that this method can produce both non-destructive patterns [55], [56], [57], and complex
trench structures [58]. These two methods offer flexible alternatives to traditional
lithographic patterning, in that no harsh chemicals are used in the process. The details of
lithography were discussed previously, so there is no need to cover that process here.
These two methods offer an alternative to lithography, allows custom designs of
surface patterns similar to lithography, with a faster turnaround time, and less investment.
As mentioned previously, using the method described by Cheng, et.al, a major advantage
of their approach is the opportunity to manufacture asymmetric features [58]. While their
research focuses on the manufacture of micro fluidic systems, these features are
important for cell patterning as well [25], [41], [59], [60], [61]. By allowing the design of
asymmetric features, there is the promise of experimental data that can quantify surface
topography influence on cell shape and morphology, as adhesion is considered the basis
of tissue architecture [62]. By varying features with precise control, as shown in Figure
16 , quantitative measurements of morphological changes may be made with respect
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Figure 16. Asymmetric laser ablation [58]
to pattern variations. This precision and variability in 3D patterns at the submicron scale
are what give the primary advantages over lithographic methods with similar critical
dimension resolution.
These are standard micromachining processes now, but older technologies such as
ion beam, etc. are used in conjunction with lithographic methods to be discussed
elsewhere.
2.1.1.4 Microcontact Printing
The term "microcontact printing" was coined in the mid- to late- nineteen-nineties
as polymer technology advanced to make patterns on the micron scale without using the
biologically unsuitable chemistries of classic lithographic patterning [63], [64], [65],
[66].The field was dominated by Harvard scientist George Whitesides, who is believed to
have first used the term, referring to his new method of precise control for self assembled
monolayers or SAMs. This new technology was primarily an advancement of nonlithographic patterning, as there were no harsh chemicals required. Initially, the surfaces
were gold, silicon dioxide (SiOa) surfaces. These were areas of interest for such activities
as manufacturing electrodes with cells patterned on them, or silicon wafers with an oxide
layer that was then patterned for biochip production [21], [65]. As discussed earlier,
though, glass surfaces prepared correctly display similar characteristics to the Si02
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surfaces. This allows microcontact printing on glass, or by using such reactants as
APTES, also mentioned earlier, the pattern can be determined, and printed with the
silane, and then bulk treated with whatever protein is desired to adhere to the pattern, thus
forming a micron-scale pattern of proteins for selective cell adherence [67].
The process begins, with lithographic patterning of silicon wafers to create the
master stamp profile in relief, or negative. Once this is achieved, a polymer mold is
made, in many cases of polydimethoxysilane (PDMS), and elastomeric polymer. Once
the polymer is cured, one surface is inscribed with the master pattern, and can then be
brought into contact with liquid suspension of the pattern target. This is much the same as
"inking" an old fashioned rubber stamp. The PDMS face with pattern and target molecule
is then brought into contact with the prepared surface, and removed, leaving a thin film of
patterned target molecule, as shown in Figure 17.

PDMS stamp

Taiset molecule

I

C oversiip

Figure 17. Cartoon of microcontact printing method [66].
As diagrammed in the cartoon, the method does seem quite simple, after the
lithographic process to make the master stamp. But the advantages are real, in that none
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of the lithographic chemistry required ever comes into contact with the biological
materials. There is no danger of residual chemistry issues, or mistakes that could damage
or destroy expensive cell cultures, or those that require painstaking cultivation, such as
neurons. By using this simple method many have had great success patterning various
cell types by tailoring the target molecule to the specific cell type, and forming patterns to
prove they could indeed, coax cells to grow in defined shapes.
2.2 Cellular Response to the Native Environment:
Development, Differentiation, Growth, and Apoptosis
2.2.1 The Cell Cycle and Differentiation Cues
2.2.1.1 The Cell Cycle
Almost all cells follow a growth and replication pattern referred to as the cell cycle.
The cell cycle is the chain of events leading to replication of the cells. The phases of the
cell cycle are broken into four distinct portions: Gi, S, G2, and M. The first growth phase,
or "gap" is begun directly after division that results in two identical daughter cells. The
Gi and G2 became known as "gap" phases because there was no discemable activity [68],
[69] seen in the microscope between the synthesis of new DNA and the mitosis portion
(where S and M come from). During Gi, size is increased, and transcription and
translation take place, building many proteins for the new cell. The S phase, synthesis, is
where the DNA is replicated. Once the DNA replication is complete, the cell goes into
G2. The chromosome pairs begin to align along the centerline of the cell, which then
marks entry into the M phase. The entire cycle is displayed below in Figure 18, adapted
from Wikipedia [70]. This cycle is simply divided into where action can be seen, things
are happening. As scientists, to study these aspects of the cell cycle on a large scale is
nearly impossible. These divisions named so easily are accompanied by thousands of
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activities inside the cell that we cannot see, such as protein manufacturing, and cellular
differentiation.

Figure 18. Cell cycle graphic adapted [70].
The initial cell of the fertilized egg in animals is capable of becoming all of the
various cell types in the body. The entire genetic code is there, and as the cell grows, it
expresses various proteins which are the hallmark of a specific cell type, but deeper
changes are also taking place. Changes in the RNA metabolism, along with the levels of
gene activation for various genes not correlating to proteins expressed on the cell surface,
those that can be seen, and levels of varying substrates [71]. All of these things are
shaped in part by the environment of the cells. Not just the physical environment, but the
social order, the types of cells that surround the developing cell [72], [73]. These all play
a role in said development, influencing the cell, and helping it along its differentiation
and growth path.
2.2.1.2 Contact Inhibition
Contact with other cells, and the extracellular milieu itself plays an important role in
the development of organisms. Developing animal cells interact in a complex manner

28

with each other. This entire phase of development of the growing organism, the
individual cells are responding to stimuli such as the surfaces of other cells they are in
contact with, the extracellular matrix, temperature, etc. They also are susceptible to
soluble chemicals, proteins and the various hormones, growth factors, and cytokines in
the extracellular milieu. All of these changes not only are affected by the processes of
differentiation, but they have an effect on the differentiation process itself in a feedback
loop mechanism of control. All of the aforementioned growth factors, implied
transcription factors, cytokines and physical stimuli should represent targets for
experimental control of morphogenesis. With this thought in mind, the discussion will
now focus on the selected avenues of approach currently in use to control cell
morphology, adhesion, and patterning.
With the early cell culture experiments, cells were noted to not grow exactly as
they had in the original tissue, but could survive for many days was a scientific feat in the
early nineteen hundreds [13]. Cells taken directly from an organism, and placed in
growth medium in a dish or flask, are known as primary cells. It is common knowledge
that primary cells grow only in two dimensions, the x and y directions, using the growth
surface as a planar reference to the Cartesian system. They will grow until all of the cells
touch boundaries all around. Once there is contact with the wall of the dish or flask, or
other cells, growth and spreading is then down regulated. This is phenomenon has been
termed "contact inhibition" [73], [74]. As the cells grow and spread out, they stop once
they make contact with other cells, and once they fill the available growth area, their
metabolic rate slows [75], [76], [77]. This growth inhibition is not exhibited in cancer
cells, one of the primary symptoms of disease, unchecked growth and replication. This
fact alone should make surface patterning and contact-based guidance strategies a

valuable tool in the anti-cancer arsenal. By ascertaining the mechanism of this contact
inhibition, that cancer cells do not normally exhibit, the knowledge could well translate
into effective treatment strategies aimed at returning cancer cells to a state of exhibiting
contact inhibition. There is experimental evidence of the ability to return the contact
inhibition to cancer cells by treatment with a plant-based protein of the carbohydrate
binding lectin family concanavalin A [78]. Lectins are a family of proteins that function
as simple carbohydrate recognition and binding moieties. The lectins are heavily relied
upon in the human immune system, which also hints at possible immune-activation
against cancer, given the appropriate stimulus. Plant-lectin-binding implies the presence
of abnormal surface glycoproteins, which are obviously recognized by the human
immune system as self antigenic, and therefore non-inflammatory, or non-responsegenerating. Further evaluation would be merited, and could produce a vaccine of sorts,
against cancer.
2.2.1.3 The Extracellular Milieu
Examining the physical context of the cell culture environment, and the effect that
physical contact with varying surface features such as channels, protrusions and barriers
of various scale, can hold the answers to many questions about contact inhibition, growth
guidance and characteristics of both normal and cancerous cells. Results will now be
examined from many studies that will enlighten as to the suitability of the various
techniques previously discussed to not only affect cell morphologies, and growth
patterns, but to also use these techniques to predetermine cell growth patterns and
morphologies. Can this be done successfully? Can it be repeated? What level of precision
might be expected? The challenge will be to define mechanisms for the observations, and
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in doing so, can progress be made toward designing and implementing man-made,
bottom-up tissues? These tissues could be used as test beds for in vitro experimentation
that more closely resemble the in vivo reality. Can these tissues be refined to the point of
using them for implants?
2.2.2 Apoptosis Shapes the Differentiation Process
Apoptosis has been termed "programmed cell death" and is a normal process in
the development and continuing life of complex, multicellular organisms [79], [80]. It is
crucial to homeostasis, and is a highly complex process, regulated on many levels,
through many pathways [79]. Aberrations in the apoptotic machinery result in diseases
like cancer, arthritis (autoimmune) and perhaps even degenerative disorders [81].
Scientists have observed the phenomena for many years, and are always
discovering new pathways leading to the same end: the demise of the cell [82], [83].
Three of the common, well characterized pathways include intrinsic and extrinsic, and the
perforin/granzyme pathway. These three pathways have many different triggers or
initiators, but all are what is known as caspase dependent. This simply means the
pathways converge at the final step toward death, caspase-3 activation. Caspase-3 is the
main effector caspase, one of many proteins of a family of tightly regulated enzymes that
perform roles in the apoptotic cell death cycle. Many of these enzymes exist as a proenzyme, and activation of one pro-enzyme, or pro-caspase, activates more copies of the
enzyme, which then activates other caspases. This is the classical enzyme cascade, and
amplifies the reaction at each step, until, at the caspase-3 portion, there is no turning
back, and the cell has reached a certain commitment point. At that point the negative
physiological changes begin to be insurmountable, and the cell dies.
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The physiological changes seen the earliest are cell shrinkage and pyknosis, or the
irreversible condensation of the chromatin DNA material. These changes are visible
within a few hours in culture. The pyknosis and shrinking of the nucleus can be used to
quantify the extent of apoptosis in culture, via image analysis [84]. This Nuclear Area
Factor, introduced by Dr. Mark DeCoster, can be very useful for quantification of
apoptotic cells in biocompatibility testing. Pyknosis, and nuclear shrinkage is said to be
the classic feature that is characteristic of apoptosis, but other features occurring later can
be easily identified as well. "Blebbing" is the appearance of rounded, detached cells in
the area of apoptosis, which is a singular cell-, or small cluster of cells-type of process,
and does not usually spread to large areas of cells. Blebbing and overall shrinkage can be
seen easily during cytoplasmic condensation, as the cells prepare to be phagocytosed by
macrophages or parenchymal cells. All of the processes of apoptosis can be summed up
as simple packaging for disposal.
The packaging for disposal analogy is a key for differentiating apoptosis from
necrosis, another form of cell death. Necrosis is a process where the cell actually
explodes and dumps it contents into the interstitial space. Much of the cellular contents
are not normally exposed, especially reactive proteins such as the cytochromes, contained
in the mitochondria. When these are turned loose in to the extracellular milieu, they can
cause inflammation and surrounding cells to become necrotic. Therein lies the most
visible difference: apoptosis is a process of shrinking, such as when one packs up and
moves to a new home, where all of the items from the old home actually fit in a much
smaller truck, with necrosis, everything is sent out of the cell in disarray, as if a tornado
hit the home form the moving analogy. This difference is exemplified when a virus
invades a cell and hijacks the translational machinery to produce many more virus
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particles. At a certain point, the cell membrane fails, and the rupture lets the new virus
particles out into the extracellular milieu, causing inflammation and spread of infection, a
growing radius of cell destruction. This is a stark contrast to the processes involved in
apoptosis which do not release cellular contents, become phagocytosed (which prevents
inflammation and necrosis in the surrounding tissue). An interesting note to differentiate
is that the phagocytic cells do not produce inflammatory cytokines upon ingestion of
apoptotic cells, which is contrary to the virus example, in that upon phagocytosing
necrotic tissue elements, inflammatory cytokines are produced [80].
The mechanism or mechanisms of apoptosis require a great deal of energy, as
does packing to move. This particular trait can confuse some when testing for
biocompatibility, as the MTT test is often used. This test measures metabolic activity, and
can be hard to interpret, based on the fact that it works by chemical processes involved in
the mitochondrial metabolic chain. As stated, a cell can be dying, and show an increased
mitochondrial metabolic rate, while a cell that is not yet ruptured, but is in the process of
necrosis, may show reduced activity due to mitochondrial injury. This is a point to
consider when designing experimental procedures, but it can still be used effectively as a
test, if the hypothesis is arranged correctly, and supporting tests are made, so as to verify
and be certain to differentiate between the two processes.
As mentioned earlier, all of the pathways of apoptosis converge at caspase-3, but
their initiations are different. In the extrinsic pathway, initiation is accomplished by
receptor/ligand binding. The receptors are from the tumor necrosis factor (TNF) receptor
family [79], [80], and receive external cell signals that can lead the cell to apoptosis.
Again this process converges at the caspase-3 executioner protein, with the intrinsic
pathway, and the perforin/granzyme pathway.
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The intrinsic pathway is initiated by many things, but is not specifically receptor
mediated responses, such as the way removal of nerve growth factor results in death of
the nerve. Other factors include radiation damage to DNA, toxins that have no specific
receptor, hypoxia, hyperthermic shock, etc. These things result in a change in the
mitochondria, which then releases proteins that start an apoptotic cascade, and later in the
process, release endonucleases and other proteins that seal the deal, accelerating the
apoptotic process. For this reason the intrinsic pathway is sometimes labeled the
mitochondrial pathway. While it is possible for the events to take place in such an order
that the mitochondrial changes are initially bypassed, cascading caspases will result in the
late phase changes that accelerate the intrinsic pathway.
The perforin/granzyme pathway is in some instances the same as the extrinsic
pathway, as cytotoxic T cells displaying the Fas ligand (FasL) interact with the Fas
receptor (FasR) on cells, initiating apoptosis. In other cases, such as viral infection with
virile protein expression on the cell surface, the T cell adheres to the infected cell and
secretes perforin. The protein perforin makes a hole in the cell membrane (perforates it),
and then the T cell puts granzyme A and granzyme B containing granules through the
pore to initiate caspase cascades and thereby initiating apoptotic destruction of the
infected cell before the virus can propagate. Figure 19 shows a diagram of the cascade.
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Figure 19. Apoptosis diagram, illustrating convergence at
caspase 3 [80].
2.3 Cellular Responses to Patterning In Vitro
2.3.1 Responses to Mechanical Surface Modifications
2.3.1.1 Knife-Cut Patterns
The first approach to be discussed will be the simpler mechanical methods to
surface modification. These methods date back to the nineteen seventies, when scientists
at Duke University Medical Center attempted growth of heart muscle columns from
dissociated chick heart muscle cells [85]. The patterning methods included coating tissue
culture ware with rat tail collagen, then blocked cell binding with a coating of agar film.
To demonstrate preferential binding, they used exacto knives to cut slits in the agar film,
exposing the collagen underneath. Cells were then seed on the prepared surface, revealing
the differential binding.
The Duke scientists were able to get cells to align in the slits in the agar, and
produce column of aligned, synchronous beating heart cells. These were tested and used
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for electrophysiology experiments. The authors also contend that due to the relative
similarity of the columns to the in vivo orientation of heart muscle cells, their results of
the electrophysiology experiments would be closer to reality than similar results of tests
performed on monolayer cultures [85]. These results show success, repeatability, and
offer a modest level of precision. The resultant tissue was received as an improvement on
the test model, but there is a long way to go before looking toward implantation.
2.3.1.2 Laser Ablation
A slightly less simple method of surface mechanical modification is the removal
of surface material to form contact guidance patterns for cell adhesion. The laser ablation
method is included here as it is much less physically complicated, than the acid or base
etching encountered in photolithography. As precision control of the laser is required to
modulate pulse length to femtoseconds, manipulate the beam trajectory on the
micrometer and nanometer scale, control beam angle to extremely tight tolerances, and
penetration depth of the beam on the nanometer scale, this process does not truly qualify
as "simple". By current standards, the requisite computing capacity for these precise
controls can be supplied by a personal computer that can be purchased for about five
hundred dollars. Thissen, et al. described a method of burning off surface coatings and
etching into the surface itself to create 3D surface architecture [55]. Figure 20 shown next
is a digitally enhanced photo of their cellular results.
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200 urn
Figure 20. Selective binding of Bovine corneal epithelial
cells. Stained with pico green [55].
Most of the laser-based processes do take advantage of chemically modified
surfaces [86], [87], [88], but it is valuable to know as much about the applicable
technologies as possible to implement the materials and equipment available to the
current research question being explored.
2.3.1.3 Simple Surface Scratches
Other simple methods include simply scratching the surface of a glass cover slip,
and then determining how the cells react. In the case of the Polish scientists at
Jagiellonian University studied contact guidance of chick embryo neurons with that
model. By placing a 0.2um scratch (width, depth), they found the growing neurites would
follow along the edge of the scratch [89]. There is plenty of current evidence to support
the contact guidance conclusion, as many reports have been made about the effect of
surface topography on cell morphology and adhesion [56], [90], [91], [92]. Many of these
studies have shed light on the exact nature of what makes a cell adhere to a given surface,
and the preferential factors from the cell perspective [62], [66], [90], [91], [93], [94],
[95]. Cell morphological polarity, for example, is regulated by the cadherin family of
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adhesion proteins, and cell polarity plays a key role in determining the fate of the cell
[96]. The cadherins not only mediate focal adhesion attachment to substrata, but are also
vital to cell-cell contacts [97]. Chen and Obrink [97] showed in nineteen-ninety-one that
the cadherins were necessary for cell contact inhibition by transfecting cancerous cells
with cadherin expression vectors. The transfected cells exhibited contact inhibition.
Baker and Humphrey's observation that cancer cells can exhibit contact inhibition when
treated with the correct glycoprotein recognition protein came before the identification of
the cadherin family, and the detailed mechanistic explanation of cell-cell interactions
[78]. These results, when regarded side by side point to the conclusion that mechanical
methods of surface modification to manipulate cells may be used with what is known
about contact guidance and contact inhibition.
2.3.2 Lithography Induces Guided Cellular Responses
2.3.2.1 Early Lithography Successes
The history of lithographic methods of patterning for cell guidance dates back to
the nineteen sixties and seventies, when early experiments to enhance the adhesion of
cells in culture and control their growth patterns were first taking place [98], [99], [100].
These early attempts used simple grid patterns with palladium [98], [100], [101]. This
mode of cell confinement was first reported in 1967, and was subsequently repeated by
many [98], [100], [101]. This method enjoyed success, with notable results of defined
patterns being observed, and successful confinement to said patterns. These successes
were expensive, as palladium is a rare metal, and precious, and the application process
needed special vapor deposition equipment. As was discussed earlier, surface topography
is critical in cell attachment, hence it is critical in guidance. Letourneau's work showed
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cellular preference for the biological coating of the amino acid ornithine over the
palladium coating, but palladium was preferred over bare polystyrene [100]. As is known
of polystyrene, cell adhesion on bare polystyrene precipitated the move to various surface
treatments to decrease the cost of tissue culture wares, leading to the conclusion that the
cells were not choosing the palladium in as much as they were choosing a micro- or
nanoscale architectural change over the less hospitable surface of the polystyrene. The
others showed similar results.
2.3.2.2 Complex Photolithographic Methods
Here, begins the more complex arena of true engineering lithography. These
processes, as discussed earlier, require specific skill sets, training, advanced knowledge,
and expensive equipment. Given the nature of lithography and its use in highly advanced
micromachining for the electronics industry, with the current applications at the
nanometer scale, the usual state of affairs is that if one knows biology, one probably does
not know much about lithography, and vice versa. This often brings interdisciplinary
collaborations in play to achieve significant results [25]. Such is the case with many
studies, such as those occurring here at Louisiana Tech in the early years of the two
thousands. Dr. Mike McShane, an engineer practiced in lithographic micromachining
partnered with a Dr. Mark DeCoster, a neuroscientist at the Neuroscience Center of the
LSU Health Sciences Center in New Orleans. The team worked together to produce
patterns on glass which were a hybrid of lithography technique and layer-by-layer
assembly (LbL). By designing the pattern protocol, they were able to create differential
patterns, fluorescently labeled, that could be used to study neuronal cell attachment. This
work was very successful and it showed high precision of patterning, at a scale down to
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ten microns [23]. The patterns also enabled the neuronal cells to exhibit specificity for the
pattern with great fidelity. Preference for one type of nanofilm as opposed to another was
also on display, as the cells preferentially chose the film composed of secreted
phospholipase A2 (SPLA2) over PLL, a previously discussed, well characterized cell
adhesive coating.
Some groups start the process with silane treatments similar to those discussed
previously, and create blocked areas on top of the silanes to then discourage cell adhesion
[102]. This method also shows great fidelity and precision, and the lithographic
patterning uses a polymer film photo resist that is easy to apply, and requires no special
machinery. Indeed, the results obtained by Lorn, et al. were achieved using no special
equipment, save for common tissue culture hoods, and a chemical fume hood. This
method, or rather, combination of methods is clever, and cost efficient. It also happens to
work.
Others have used lithography to create wide ranging 3D surface topography,
which includes both surface microgrooves and microsteps to test the ability of neurons to
react to the topographical changes [103]. Hirono et al. conclude, based on the results of
their study, that the nerve cells cannot surmount much of a vertical challenge. Their tests
included multiple variations of the microstep size, as well as multiple depths of the
grooves, and after a certain point, the cells could not or would not overcome the barrier.
This has been noted in the author's four years of cell culture experience as well, that cells
will grow up to, but not on, the vertical surfaces of the containers in which they are
grown. In the case of flasks, often the flask has an angled surface to elevate the neck
opening as seen in Figure 21. This angled neck will support cells, but is meant to help
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maintain sterility by limiting the exposure of the opening to liquid media, which can spill.
This researcher has observed the more aggressive cell lines such as the rat glioma

Figure 21. Tissue culture flask showing angled neck.
CRL 2199 grow up the angled surface. Primary cells, non-cancerous cells, and the
transformed "immortal" cell lines will not attack the slope, which is of great interest, and
suggests another avenue of study for surface contact guidance. Similar experiments
concerning micro channels and neurons were performed by Mohoney et al., finding that
the channels reduced the architectural complexity of the neuronal cells [104]. This
suggests a need for diversity in the guidance cues to improve cellular response.
During development, the growing nervous system extends neurites to the outer
reaches of the body. This growth takes place with amazing precision, and the neurites are
guided by diffusible signals and by surfaces of the cells they are growing [68], [105].
Nagato et al. focused on this aspect of guidance and took an approach similar to the
Hirono group, but chose to create patterns of higher precision to more closely resemble
the dimensions of a small nerve bundle, which may be used to guide growing neurites.
The group determined that contact guidance along micromachining aspects parallel to the
polarity of the cell was common, but that perpendicular contact guidance was exhibited
exclusively in the central nervous system. This is an interesting result, and could be
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important in the design of regenerative constructs for spinal injury using many of the
techniques outlined here [106].
These various approaches using similar methodology show excellent
reproducibility and exhibit impressive levels of precision, owing to the advanced state of
the art lithographic process. These processes are the heart of the computer industry,
where critical dimensions are in the tens of nanometers. The benefit is that biological
sciences are now able to incorporate these technologies with relative ease when compared
to twenty years ago [107]. There are obvious advantages to these methodologies, but
current results are rudimentary, and are not close to tissue level organizational control.
This study chose not to use any of the complex photolithography methods, but used a
variation of soft lithography that will be discussed in the next section.
2.3.3 Chemical Surface Modifications and Microcontact
Printing Induce Adhesion and Guided Growth
Patterns
2.3.3.1 Soft Lithography Builds on Chemical Surface
Modification
Chemical surface modification that has already been discussed method-wise
includes layers of adherent peptides, proteins, and other biopolymers on tissue culture
surfaces. There are also the self assembled monolayers of various molecules, including
the electrostatically bound poly ions of the layer by layer assembly method. Surface
silanization is to be included here as well, along with the so called "soft lithography"
techniques of microcontact printing. Moreover, micropatteming results will be discussed
which were obtained not through soft lithography, but by variations of the "dip pen"
nanolithography process.
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All of the aforementioned procedures have the common feature in that they all
add some chemical structure to the surface, with application method being the greatest
difference. They all use different surface bonding techniques as well, but the results seen
show very similar successes, and all the methods together promise additional levels of
control of cellular patterning.
2.3.3.2 Poly-L-Lysine (PLL)
The first adhesive polymer to be examined is PLL, one that has been used in
DeCoster's lab for years. PLL adhesion is commonly accepted, and is in widespread use
[17], [24], [95].The results of PLL treatment are actually variable. Simply coating
surfaces to cover with a layer of 0.005% PLL in deionized (DI) water, and letting it sit for
1 hour or more, will achieve cell adhesion results. With too high a concentration,
approaching 0.05%, the treatment becomes cytotoxic [108]. This approach only offers
adhesion control, unless applied after patterning, as many have done [23], [24], [49],
[52], [95], and have been discussed already. PLL monolayer application is much more
consistent than coatings of large biomolecules such as proteins, due to their tertiary and
quaternary shape characteristics. The cells prefer a more adhesive surface, and tend to
achieve a level of differentiation and gene expression that correlates more closely to the
in vivo situation in regards to shape, and production of various proteins that can be
measured [62], [109].
2.3.3.3 Surface Silanization
Using a silane surface treatment can improve the durability of surface coatings
layered on top of the silane layer [4], [36], [46], [110]. This gives the layers the added
stability of non-hydrolysable bond to the surface. With this surface pre-coating, non-
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adhesive regions are easily patterned as well, giving more precise control over cell
patterns and shapes [110].
This siloxane derivitization lends itself especially well to microcontact printing.
The use of elastic polymer stamps that are dipped into a patterning substrate, and then
brought into contact with a surface, benefits from having a reactive group available on
the surface as discussed previously [111]. Siloxane treatment is similar to the LbL
method, but is not based on electrostatic attraction. The bond is covalent, but the end
result is similar: microcontact printing invariably requires a means of adhesion to the
surface be it electrostatic, covalent, or undefined as the attraction for thiols to gold that
was the basis for some of the first self assembled monolayer (SAM) research [65], [112].
There has been a great deal of success using all of these methods, and research
into new applications continues. The challenge now is to characterize the binding and
morphology of the surfaces. There are methods available to quantify mRNA production
to determine the developmental state of different cell types that can be used to ascertain
each application's appropriateness for each cell type [95], [113], [114].
As progress is made these methods will become more reproducible, increase
fidelity, and can be the first steps toward tissue level organization, once the
characteristics of each surface treatment is determined and how to apply them toward 3D
patterns.
2.4 Literature Review Wrap Up
The apoptosis information was vital to the first goal stated for this project of
developing a simple model of apoptosis. While reviewing apoptosis in-depth, the notion
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occurred that this process could be used in conjunction with scaffolding and patterns to
create a more biomimetic in vitro scenario for 3D cell growth.
All of this information in the review is helpful for the second goal pertaining to
the scaffolding. Evaluation of the scaffold material in light of this knowledge makes the
scaffolding an attractive platform for use with applications of patterning and apoptotic
sculpting, as discussed elsewhere in this work.
Much was learned about these various techniques of surface modifications and
patterning, in order to choose what methods would be best suited to the chosen goals of
each portion of the project. All options were discussed with various faculty members,
searching for alternatives to the current adherence blocking strategy, in an effort to
identify suitable methods that could be used or adapted to use in cell culture applications.
As the reader will see, it is this literature review for the third stated goal of this projectincrease the fidelity of cell adherence to patterns deposited by the NanoEnabler® system
by developing a novel cell-adherence-blocking strategy which yielded and developed the
concept for the 3D cell model of tumor progression discussed later.

CHAPTER 3
MATERIALS AND METHODS
3.1 Apoptosis Testing
3.1.1 Glutamate Delay of Staurosporine Induced Apoptosis
3.1.1.1 Staurosporine, an Apoptotic Stimulus
Staurosporine (STS) is a bacterial product that is chemically a multicyclic indole
alkaloid, C28H26N4O3. It is a non-specific protein kinase inhibitor which acts as a potent
apoptotic stimulus in many cell lines. An observation in the DeCoster lab of
staurosporine-treated cells showing morphological difference in similarly treated cultures
pre-treated with glutamate brought a great deal of attention. The hypothesis was formed
that apoptosis could be delayed by pre-treatment of glutamate, which is the major
excitatory neurotransmitter in the central nervous system (CNS). A goal was set to
determine cell area changes over the course of the apoptotic process. This information
would be used to create a model of apoptosis that could be used to determine the
apoptotic state of a culture based on its comparison to the model. The cells used for this
project include rat cancerous cells, CRL 2199, and CRL 2303, normal rat astrocytes, and
human Jurkat lymphocytes.
3.1.1.2 Calcein Fluorescence Area Measurement
Procedures
Experiments were designed to test the hypothesis. The experiments included
control groups of astrocytes obtained from Lonza, Jurkat cells CRL 2570 and CRL 2199
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rat glioma cells. The Jurkat cells and the CRL 2199 line, both obtained from American
Type Culture Collection (ATCC), were to be compared to apoptotic groups treated with
20 uM STS and 20 uM STS groups pre-treated with ImM glutamate (GLU) solution.
These experimental groups were plated in twelve-well tissue culture plates from Greiner,
at similar cell densities at each iteration of the experiment. To quantify the differences
between the cultures, the live (healthy, or apoptosing) cultures were fluorescently stained
with Calcein AM®. This staining was achieved by incubating cells in a Locke's solution
with 0.2% Calcein AM® and 0.1% pluronic acid for 1 hour at 37°C and 5% C 0 2 .
Fluorescent images were recorded with Leica DMI6000 inverted fluorescence
microscope, and Leica DFC 290 black and white three megapixel digital cameras.
Imaging proceeded over multiple fields of standard wells of twelve-well tissue culture
plates. The multiple field images were then analyzed using Image Pro® software to
determine the calcein positive, or fluorescing, cell area. Cell areas for each treatment
condition were compared at multiple hourly time points. For each imaging session the
"reverse time point method" was used, a time consuming and difficult organizational
method requiring addition of metered reagents at times such that when the experiment
was ready for staining, different time points were all ready to be stained with
fluorochrome at the same time. Experiments were repeated at least in triplicate, creating
multiple data sets of cell areas to be graphed for comparison at varying time points for
each group: control (treated only with Locke's solution, a sterile sugar and salt solution),
STS treated, and GLU pretreated STS.

3.1.1.3 DAPI Nuclear Area Measurement Protocols
The same treatment protocols were then followed, again using all three cell types
(in separate vessels) to determine effects on nuclear material, as apoptosis presents a
specific endpoint scenario in regards to DNA: there is fragmented DNA that shows
specific patterns when electrophoretically separated. This pattern is called DNA
"laddering," as the fluorescent bands on the gel are evenly spaced and resemble a ladder.
Dr. DeCoster previously introduced the Nuclear Area Factor as an apoptosis diagnostic
measure, and has shown a decrease in area correlating to progression of apoptotic
processes. With this in mind, the treatment protocols were run, but this time the
fluorochrome used was 4, 6-diamidino-2-phenyindole or DAPI. This molecule
intercalates between the DNA double helix molecules and fluorescent intensity of the
molecule increases when bound to DNA. Cells were fixed at the time point specified,
using ice cold absolute methanol, rinsed and covered with PBS until ready for staining.
DAPI solution was prepared by adding 0.1% dye to Locke's solution and vortexing.
Plates were incubated overnight in refrigerated storage. Stained cells were imaged on the
Leica DMI6000 as before, with image analysis providing data on nuclear area. Multiple
time points for each treatment condition were recorded as with the Calcein experiments.
The areas for each time point and condition are then compared with graphical analysis
3.1.1.4 MTT Assay Correlation
The previously discussed experiments were mirrored with the MTT assay. MTT
or dimethylthiazol diphenyltetrazolium bromide is yellow in color, but when added to
living cells is broken down to a purple colored product in the mitochondria of the cells.
The purple product is measured in the Thermo Scientific Multiskan Spectrum plate
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reader, for high throughput. A complete description of the assay can be found in
Appendix A. The absorbance is quantified, and in relation to the number of cells in the
culture, gives a qualitative measure of culture health, i.e. healthy cell cultures or controls
will produce a high reading, where apoptotic cultures will produce a lower reading. This
data can be charted and compared at specific time points.
3.1.1.5 Caspase 3 Measurement
As previously mentioned, caspase 3 (casp3) is a major effector enzyme in the
apoptotic process. In order to test whether the observations were indeed delay of the
apoptotic machinery, a molecular biology assay was used to determine casp3 enzyme
levels at similar time points with similar treatment protocols to the previous experiments.
The CASP3C kit from Sigma-Aldrich was used to determine the casp3 levels of
astrocytes and CRL 2199, or Jurkat T Lymphocyte cultures treated again with STS, or
pretreatment with glutamate and STS, and compared to controls treated with Locke's
solution at similar time points to the previous experiments.
Cells are plated as previously discussed. Again, treatment protocols are similar to
earlier experiments. The protein extraction of the cells must be accomplished to measure
casp3. Upon completion of the time points specified by earlier experiments, cells are
lysed (broken apart) with a lysis buffer which will then be collected and centrifuged. The
lysis buffer chemistry is such that enzymes and similar proteins stay in solution, while
structural proteins and membrane bound proteins do not. After this extraction, the
enzyme containing lysis buffer is diluted with the assay buffer and the casp3 synthetic
substrate in a ninety-six well plate for use in the Thermo Scientific Multiskan Spectrum
plate reader. The solutions are incubated for ten to twelve hours (the calculation takes
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into account the time of incubation). The assay uses p-nitro aniline (pNA), a molecule
which can be quantified by spectrophotometry at 405 nm using Beer's law, in Equation 1.
A = eLc

(1)

In Equation 1, the absorbance (A), is equal to the molar extinction coefficient ( • )
multiplied by the path length (Z) and the concentration of the solution. Knowing the
absorbance, and the molar extinction coefficient, and a path length of the
spectrophotometer, we can then calculate concentration. One prepares standard curve by
measuring absorbance of solutions prepared at specific concentrations. The values are
plotted and a best fit line is produced which will be used to determine the concentration
of the experimental protein extraction. In Figure 22, an example of a standard curve for
one of the casp3 experiments is presented.

Figure 22. Example of pNA standard curve performed at
each iteration of casp3 experimentation.
Then measurement of the unknown protein solutions proceeds, and is plotted on
the standard curve to give a concentration of pNA produced from reaction of the
synthetic substrate analog for the casp3 enzyme. The appearance of a yellow color and
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increased readings from the spectrophotometer indicate increased casp3 activity. This
increased activity is known to correlate with escalating apoptotic death outcomes.
Activity level is determined by equation, as well. Shown next in Equation 2, is the
example calculation of casp3 activity.
„

.

,

casp3 activity =

umols pNA produced x dilution factor
reaction time in minutes x volume of sample in mL

,_.

(2)

This test shows great specificity and is supplied with purified casp3 enzyme as a
control, and along with measurement of control groups is repeatable. The data from
multiple time points and treatment conditions can then be charted and compared.
3.1.1.6 Image Analysis of STS Treated Cultures with
Image Pro Analyzer®
Images were collected as stated previously, and analyzed with Image Pro
Software version 6.0 developed by Media Cybernetics. All images were assessed for cell
area or nuclear area, as appropriate for the staining condition (Calcein AM® stains the
whole, live cell, whereas DAPI stains only the nuclear material). The software also
calculated the roundness of the bright structure, with the unit circle reference being a
roundness value of one. With the extremely high signal to noise ratio of fluorescence
microscopy, the software can, with little operator input, determine the number of bright
fluorescing objects, which are the cell bodies or the nuclei. The illumination pattern
enables the number, roundness, and cross-sectional areas of these objects to be
quantified.
Cells that have grown together can be difficult to distinguish. The software can, in
many cases, use an average size threshold, or another parameter of chosen by the user to
distinguish abutting or overlapping cells, but user input is sometimes needed to ensure
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accuracy. Multiple frames for each experimental condition were processed. In addition,
each condition had multiple time points. Each time point was repeated in triplicate for
each condition, at each repetition of the experiment. Data were exported in Excel®
format and used to chart and compare differences between conditions and time points.
3.2 Scaffolding Tests
3.2.1 CRL 2020 Cell Culture Testing
3.2.1.1 Cellulose Scaffolding for Tissue Engineering
Applications
Cellulose scaffolds produced by the lab of Dr. Yuri Lvov were tested as a tissue
engineering platform. Experiments were designed to visually and quantitatively assess
the scaffolds ability to support and encourage cell invasion, growth and differentiation.
3.2.1.2 Scaffolds for Microscopy
CRL 2020 human brain cancer cells were obtained from ATCC. Cells were
cultured as recommended in RPMI 1640 plus 10% Fetal Bovine Serum (FBS) as growth
medium. Both gelatin and cellulose fibers/gelatin micro scaffolds (with 75 wt% fibers)
were cut into thin slices approximately 1.5 mm thick, sterilized using 70% ethanol, and
washed with phosphate buffered saline (PBS). Two additional PBS washes completed
preparation. Cells were trypsinized to suspend the cells, and the suspension centrifuged at
250 X g to pellet. Pelleted cells were resuspended in fresh media, counted and diluted to
deliver a 1 ml cell suspension with 2x10 cells to seed onto the matrix. Matrix materials
were seeded in single wells of 24-well tissue culture plate. After seeding, the media was
changed every other day and the cultures were maintained for 16 days at 37 °C and 5%
C0 2 .
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At 17 days in vitro (DIV) culture, the brain cancer cells were stained using
Calcein AM® as described previously. Cells were imaged using a LEICA DMIRE2
Confocal Laser Scanning Microscope with multiphoton source or Nikon Ti 2000
fluorescence microscope. Specific images are labeled as to origin.
3.2.1.2 MTT Testing
MTT testing was chosen to compare the progress of cell cultures with the
fiber/gelatin scaffold, gelatin scaffold, plain copier paper, and no scaffolding (control
group). CRL 2020 cells were seeded at similar density to the imaging experiment,
proportional to the smaller construct size used, approximately 1/8 of the disc-shaped
scaffold. Time points were defined at 1, 3, 9, and 17 days, with the 17 day terminal
matching previous work. The scaffold portion was removed from the culture well and
assayed with the MTT method as stated earlier. The culture well used for each scaffold
sample was also assayed as a normalizing factor to account for any cells that may have
grown in the dish, and not the scaffold construct. Experiments were repeated in triplicate,
and data were charted for comparison.
3.2.2 CRL 2303 Cell Culture Testing
3.2.2.1 Scaffolds for Imaging
CRL 2303 cells are clonal lines similar to the CRL 2199 cell line discussed
previously. The CRL 2303 variety expresses a certain transfected gene more actively than
the CRL 2199 variant. This makes them well suited for visual assessments, as the gene
expressed is an enzyme which will produce a blue-colored product trapped within the
cell when exposed to the X-gal substrate, a synthetic galactose molecule.
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Cells were seeded as before and visualized at 17 days with the Leica DMI6000
microscope. Phase contrast images were collected for appraisal.
3.2.2.2 MTT Assay of CRL 2303 Cultures with Scaffolds
MTT was carried out as described previously with the scaffolding, and time
points again of 1 day, 3, 9, and 17 days. Assays were repeated in triplicate. As before,
data were charted for comparison.
3.3 Fabricating Selective Non-Adhesive Cell Culture
Surfaces in Conjunction with Patterned
Adhesive Surfaces
3.3.1 Evaluation of Standard BSA Blocking vs. Polymer
Non-Adhesive Coating
3.3.1.1 BSA Blocking and Goals for Increased Efficiency
In the DeCoster lab, there have been many previous publications dealing with
patterned cellular responses; dating back to before DeCoster was even at Louisiana Tech.
The most recent publications on patterning, by Dustin Green in DeCoster's Lab used an
APTES coating with gluteraldehyde cross linking agent on glass cover slips followed by
patterning of PLL with the NanoEnabler® system [115]. This system deposits liquid on
surfaces via a cantilever on a silicon chip. The cantilever is hollow, and attached to a
machined reservoir for the liquid to be applied. After liquid is loaded in the reservoir, the
machine relies on microprocessor controlled servos to achieve sub-micron precision
patterns in the x and y dimensions, delivering droplets of as small as femtoliters,
depending on dwell time, and cantilever bore. This method achieved excellent results
over the short term with Bovine Serum Albumen, or BSA, a blood protein found in the
plasma portion of cow blood, applied to the surface after patterning to bring about
blockage of non-specific cell binding. The process is simplified in Figure 23.
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Figure 23. Schematic of patterning and blocking.
As the days go by for cells in culture, they modify their surroundings with
secreted proteins that can be adsorbed to the BSA coated surface. Also, proteins from the
serum-containing media can displace the BSA on the surface. These processes lead to
decrease in the fidelity of the cells adherence to the pattern over the course of days.
The actual methodology of the printing with the NanoEnabler® (NeN) system
requires a great deal of preparation, which can be done in large batches, to reduce the
overall start to finish time of each experiment. 25 mm square common glass cover slips
are washed thoroughly with two sonication baths in absolute ethanol at thirty minutes
each, alternated with deionized (DI) water, for thirty minutes each also. This is followed
by drying with compressed nitrogen stream. The slips are then oxidized in the UV/ozone
cleaner supplied with the system for one hour. The slips are placed in a covered vessel
with 50uL of APTES solution, and heated at 60° C for two hours. This is the APTES
vapor deposition stage. This is followed by curing of the silane layer at 100° C for sixteen
hours. Upon cooling the slips are incubated in a 6% gluteraldehyde solution for two hours
at room temperature. Rinsing with filtered DI water, followed by drying in compressed
nitrogen stream completes the preparation. The slips are now ready for printing with the
NeN system.
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Patterns are designed based on Green's work suggesting that larger cells such as
astrocytes prefer a larger adhesive spot, in the range of fifteen to twenty microns in
diameter, while smaller cell types such as the CRL-2303 line prefer a ten micron spot
diameter. These characteristic diameters show better capture characteristics in Green's
work, as the cells needed to be seeded in very low concentrations [115], and reflect
preceding discussions in regards to surface topography and cell adhesion. Patterns are
entered into the NeN computer, and the cantilever reservoir is filled with one uL poly-1lysine labeled with the fluorescent molecule FITC. After a process to coordinate the x, y,
and z plane controls, location of the surface to be patterned is confirmed. Printing of the
pattern at this point takes only a few minutes, of course depending on how many spots
are patterned.
Once the patterns are complete, BSA solution at one milligram per milliliter is
placed on the slip for one hour. Upon removal of the blocking solution sterilization of the
patterned slips is completed by UV irradiation for fifteen minutes on each side of the slip,
using the sterilization UV source in the laminar flow hoods in the tissue culture facility.
Sterile slips can be stored in sterile conditions for many weeks. They can then be
used whenever the cell cultures are ready. Cells are trypsinized, pelleted, resuspended,
and counted as described previously. Cells are seeded on the patterned slip in a sterile
polystyrene tissue culture dish with only 100 microliters of cell suspension. This
suspension is placed in the area of the pattern, and allowed to incubate for 15 minutes.
The number of cells can be adjusted, according to the area of patterned surface. Growth
media containing serum is then carefully added to fill the culture dish. Cells will adhere
to the patterns and show pattern fidelity for three to four days when seeded at low density
(hundreds of cells). These constraints prompted a search for a blocking agent that would
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be amenable to higher seeding densities, and longer resistance to non-specific binding.
These characteristics are needed in the design and implementation of tissue engineering
constructs.
3.3.1.2 Polymer Blocking for Increased Fidelity
The polymer is referenced in the Louisiana Tech University Report of Invention,
but the methods of its use will be described here.
Polymer is prepared in aqueous solution at prescribed concentration using Sterile
DI water, and polymer, with vortexing, and sonication if necessary. NeN cover slips are
prepared as before with the exception of the gluteraldehyde treatment. After trial and
error experimentation, it was determined that the gluteraldehyde cross linking of the
APTES layer changed the hydrophobic characteristic of the surface to a less hydrophobic
condition. With the omission, the other changes are substituting the polymer solution for
BSA solution, and seeding the cells at higher densities (thousands of cells).
3.3.1.3 Cytophobic Surface Treatment for 3D Cell
Cultures
During the empirical experimentation portion of the polymer/patterning project,
there was doubt as to the efficacy of the treatment. Dr. DeCoster suggested a different
approach for testing the polymer properties in culture. A protocol was devised to test the
polymer polystyrene, known for its hydrophobicity. Simple external circular markings on
polystyrene dishes were contrived, and the inner, cell culture surface was treated with the
polymer confined by miniscule volume to the circle. Incubation period was for one hour.
DI water rinse followed, and cells were immediately trypsinized and processed as
previously described to place a prescribed number of cells in the treated dish.
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Further experiments were conducted with entire inner surface of the vessels
coated with polymer solution. Experiments were completed comparing static polymer
treatment with dynamic polymer treatment using a shaker assembly.
3.4 Additional Information
Additional information pertaining to the methods discussed herein can be found in
Appendix A.

CHAPTER 4
RESULTS AND DISCUSSION
4.1 Apoptosis Project
4.1.1 Apoptosis and the Cell Area Factor
4.1.1.1 The Cell Area Factor
The DeCoster lab has recently promulgated a simple qualitative model of the
apoptotic process. The Cell Area Factor (CAF) is a numerical reference to the decreasing
of measured roundness of the cell. The CAF is the product of the measured roundness
and the cell area as measured by image analysis. This factor decreases as apoptosis
progresses, until the cells are compacted and ready to be phagocytosed, at which point the
factor levels off. The basic features of the hypothesis are demonstrated in Figure 24.
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Figure 24. Hypothesis of simple qualitative model of
apoptosis based on cell shape and size.
This model can be useful for categorizing the apoptotic state of a cell or culture
based solely on microscopic observations. The data collected for this work seems to
support the hypothesis. Roundness values were enumerated by the image processing
software, along with area values have been charted for the various cell types. Figure 25,
shows the roundness of Jurkats and astrocytes under experimental conditions.
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Figure 25. Roundness of Jurkat cells and astrocytes 5 hours
post treatment with STS.
The figure shows nuclear roundness decreasing in both cell types (DAPI), along
with overall cell roundness decreasing (Calcein) from the control case to the STS
treatment. Control cells have no treatment. This is significant in opposition to the necrotic
case of cell death, where the cells expand. Here it is seen clearly the nuclear material and
the cell itself is shrinking due to apoptosis.
The CAF shows dramatic change in the morphologically polarized astrocytes as
opposed to the spherical Jurkat blood cells. Referring to Figure 24, the expected response
of Jurkat cells would be to shrink, but not necessarily become more round, as their
silhouette is round already, whereas the astrocytes would change drastically to a more
round morphology. This is exactly the case, as shown in Figure 26.
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Figure 26. CAF shown for Jurkats compared to astrocytes,
demonstrating dramatic change during apoptosis.
This dramatic change in astrocytes morphology is plainly visible under the
microscopic inspection, but with fluorescence microscopy, accurate measurements can be
taken. Apoptotic changes are evident in astrocytes early on, and two hours after apoptotic
stimulus, the changes are drastic. Examples of these changes can be seen in Figure 27,
which is of control (untreated) and apoptotic astrocytes two hours post treatment.
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Figure 27. Astrocytes untreated (a), and 2 hours post STS
treatment (b).
4.1.2 Apoptosis and Cell-Cell Interactions
During the course of the apoptosis project, the observation of a change in cell-cell
interaction of the Jurkat cells was made. The apoptosis model explained previously
would not predict any cell-cell interactions amongst the Jurkat cells, a free floating
spherical cancerous cell line. Normally these cells do not interact, but after STS
treatment, there is a change. This change results in aggregation during the apoptotic
process, and then separation of the aggregates with shrinkage of cell area occurs. The
Calcein stained cells shown in Figure 28 highlight this activity.

Figure 28. Panel a) Calcein stained Jurkats, no treatment, b)
Calcein stained Jurkats at 2 hours post STS, and c) Calcein
stained Jurkats at 6 hours post STS treatment. Clumping is
circled in RED.
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This clumping process may have a basis in the apoptotic stimulus, i.e.
staurosporine may cause this action, or the apoptotic process itself may. There are known
membrane changes in cells undergoing apoptosis, including Annexin V being displayed
on the cell surface, as opposed to its usual location on the inner cell membrane. This
protein is an effective marker for apoptosis in many cell types, as there are antibody kits
to identify apoptosing cells with this application. Some of the changes must alter cell
surface proteins in such a way to cause the agglomeration. This activity is charted in
Figure 29, showing the number of bright objects for Calcein dropping off and then
increasing again, to match the bright objects for DAPI, which continue to rise linearly.
This effect seen in the DAPI stained DNA is due to the DNA being chopped up by
endonuclease caspases. This increases the number of bright objects, and they are not
clumping inside the cells, the nuclear material is being digested and packaged for
recycling.
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Figure 29 Bright objects as counted by Image Pro Plus®
software. Red series shows Calcein objects (whole cells or
clumps) and blue series shows DAPI objects (DNA with
increasing fragmentation as apoptosis progresses.
This clumping activity is interesting and should warrant further study, to examine
the mechanism of the cell-cell interaction. Elucidation of this mechanism could be of
great value to patterning in three dimensions.
4.1.3 Apoptotic Modulation and Biochemical Assessment
4.1.3.1 Glutamate Delays Apoptosis in Normal Brain
Cells and Cancerous Glial Cells
The glutamate pre-treatment discussed in the earlier section was shown to delay
apoptosis morphological progression. The delay factor is difficult to quantify with simple
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microscopy, but with advanced image processing techniques, cell area can be measured,
along with cell roundness. These can help quantify the stage of apoptosis, and when
compared to other cultures treated similarly, the net delay can be seen. Physical
variations can be seen in Figure 30. These variations are slight, but quantifiable.

Figure 30. Astrocytes. Panel a) with STS at 4 hours, b)
glutamate pre-treatment then STS, 4 hours, c) control. The
first two images in each panel are time lapse images of the
same spot; the third image is a Calcein stained sample of
same treatment condition and time point.
Comparing the control cells in panel c, Figure 30, the morphology seen is the
accepted norm. In panel b, there is obvious damage, but in comparison to the fluorescent
image for panel a, the damage is less. These fluorescent images are examples of the
images used to quantify the steps of apoptosis through cell and nuclear area, and cell and
nuclear roundness, with each frame yielding multiple data points. With the calcein
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images there may be dozens of cells, and each experimental condition had multiple time
points, with four frames per time point yielding a high number of data points for
increased statistical significance. In the case of the DAPI photos, a lower magnification
was used to increase the field size, and therefore include more data points.
4.1.3.2 Caspase 3 Assay Results Show Delay in
Appearance of Activated Caspase 3
The morphological changes during apoptosis have been discussed and
demonstrated, as have the apparent delay of the apoptotic process. The question remained
whether this was an artifact, a result of staurosporine induced apoptosis only, or if it
affected the actual mechanisms of apoptosis. With the caspase 3 assay, the question is
answered, fully. Many proteins are produced as needed throughout the life of the cell, but
the caspase exist in the cytosol as pro-enzymes. This is an inactive form of the enzyme.
Once a portion of the protein is cleaved away, enzymatic activity of the molecule is
enhanced, and the apoptotic cascade commences. The data shows a quantitative delay
shown in caspase 3 activation. The activity levels recorded by the assay imply the amount
of active caspase 3, hence as activity increases, amount of active caspase 3 increases.
This is shown in Figure 31, where the most dramatic feature is the activity of the small
amount of human recombinant caspase 3 tested.
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Figure 31. Normalized casp3 activity of astrocytes,
showing slightly less activity at 2 hours for the glutamate
pretreatment, then significantly less at the 6 hour point.
Human caspase 3 positive control shows the assay is
functioning.
As seen in the figure, the human caspase 3 shows the assay is working properly,
and the glutamate pretreatment group active caspase 3 level never gets above the level of
the STS only treatment at the six hour mark. Recall the apoptotic damage in the four hour
time point photos showing damage. Shown in Figure 32 is an example of the difference
between zero hour and six hour STS treatment. The cells on the left in (a) are the same as
the cells on the right in (b), photographed before commencement of protocol. A physical
mark was made in the external surface of the vessel to facilitate alignment to the same
cellular region at various times, enabling tracking of the same population of cells for
measurement and comparison purposes over the course of the apoptotic process.
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Figure 32. Photo of exact same astrocytes a) at t=0 and b)
Calcein fluorescent image of the same cells after 6 hours
exposure to STS.
The morphological differences are more pronounced at the six hour point than at
the four hour point. This is also based on the idea of the enzyme cascade, a physiological
feature found in many control systems throughout the body, such as the cascade of the
blood clotting mechanism. As more enzymes are activated, the overall effect becomes
more pronounced, as each molecule of enzyme produces a large net effect, with the
cascade effects becoming similar to geometric growth. This proceeds until a tipping point
is reached, and the cell cannot be recalled from the apoptotic pathway. The evidence
seems to support that apoptosis can be modulated by glutamate to a certain point,
possibly pushing the effects back only an hour or two. Ensuing experiments showed
promise for continued delay of the apoptotic process with successive additions of
glutamate. This result is shown in Figure 33, which shows a similar trend with the STS
and G+S treatments as the earlier work.
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Figure 33. Comparison of two glutamate additions, one
before and one after STS treatment (green), with STS
(blue), and glutamate pretreated STS protocol (red).
There is also a slight peak of the caspase activity for the glutamate pre-treatment
protocol in the earlier work, and can be seen in Figure 31, showing similar trending. The
repeated glutamate addition protocol was limited in repetitions and the activity levels
seem to warrant closer examination.
4.1.3.3 MTT Evaluation
The MTT assay has been discussed previously, with results for this arena of
testing being inconclusive. The graph in Figure 34 shows varying levels of mitochondrial
activity at varying time points. Correlation with the other methods is inconclusive.
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Figure 34. Astrocyte MTT data reflecting varying
mitochondrial activities for each treatment condition.
At time point 0, the mean absorbance values are slightly lower for STS and G+S
than for the control. However, the lower values are not caused by the treatments because
treatment was not started until after the imaging. At time point 2, the STS may have acted
over a long enough time to cause some metabolic depression. Time points 4 and 6
demonstrate increased activity over control groups, however. Because apoptosis is an
energetically demanding process, the increase in cellular metabolism is consistent with an
apoptotic process.
4.2 Scaffolding Results and Discussion
4.2.1 Microscopic Evaluation
This portion will focus largely on the work done in collaboration with Dr. Yuri
Lvov in 2010. The result of the collaboration was a publication in the journal Acta
Biomateriala [116].
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Digital microscopic images were recorded to visibly present evidence of cellular
invasion, growth, and differentiation. The following image, Figure 35, shows a confocal
microscopy phase contrast image and the subsequentfluorescentimage. The two images
were then merged with image analysis software to provide the third image in each panel

Figure 35. Confocal images of CRL-2020 cell in: gelatin
(top panel a: phase contrast; b: confocalfluorescence;c:
merged image); and scaffold 75% cellulose/25% gelatin
(bottom panel, a: phase contrast; b: confocal fluorescence;
c: merged image) [116].
showing the overlay of the fluorescence on top of the phase contrast image. The
gelatin/fiber scaffold (lower panel, arrows) is showing organization of the cells along the
fiber surfaces, allowing a place for the cells to adhere. The arrows in the upper panel
indicate the leading edge of the gelatin with cells seeded. Notice the difference in
morphology between the two, both seeded at the same density, and grown in the same
incubator for the same amount of time. The fiber/gelatin scaffold shows the cell are
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elongated and assuming their normal morphology. The gelatin alone in the upper panel
shows evidence of undifferentiated growth. The cells have enough support to grow, but
the target is to achieve growth and differentiation. This is a positive result, nonetheless,
as it demonstrates the gelatin's ability to support the cells. Taken together, the two results
suggest there is a better ratio of fiber to gelatin that may encourage greater growth while
still allowing for differentiation.
The fluorescence images, examples shown in Figure 36, demonstrate similar
morphologies to the confocal images, with cell-fiber alignment obvious.

Figure 36. Fluorescence imaging of CRL-2020 cells with
gelatin (upper panel) and 75% cellulose fiber and gelatin
(lower panel). Panel: a) phase contrast; b) epifluorescence;
c) merged image [116].
The fluorescence images show similar alignment of the cells with the fibers,
though not to the extent shown on the confocal images. Confocal microscopy produces
much more precise images with its laser illumination of a very fine section of the sample,
termed a z-section. This is a reference to the z-plane of the coordinate system, as the laser
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illuminates on one plane for each image, with user-defined settings for the thickness of
the plane.
4.2.2 MTT Data
The MTT assay was used to measure the cell growth with the scaffold over the
course of the experiment. These data, shown in Figure 37, shows an increase in the
metabolic activity of cells growing in culture with the scaffold.

Figure 37. CRL 2020 MTT data for cell grown with and
without various scaffolding.
The cells are slightly behind the control group at all points until the last. Fiber and
gelatin together (blue, labeled "fiber"), and the gelatin alone rebound nicely by day 17
and are ahead of the control groups then. The paper group, samples of common printer
paper show some cell invasion, but the density of the fibers of paper may impede too
much. A photo of the whole plate in Figure 38 shows purple formazan crystals, the
product of the MTT reaction with active mitochondria.
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Figure 38. Day 7 MTT assay in 12 well plate. Note fiber
scaffold in (a) outlined in red. Also see printer paper in (c)
outlined in red. Gelatin in (b) and control groups in (d)
show little difference to the eye.
The picture shows many pieces of information. In "a," the fiber construct has
shifted, revealing an outline of its previous position. For this reason, the wells were tested
as well, after scaffolding was removed. A similar circumstance has arisen in the wells
labeled "c," with the printer paper. Wells labeled "b" and "d" are gelatin and control.
These appear to be no different, but with the assay, differences were revealed, and are
seen in the preceding chart.
4.2.3 Scaffolding Implications
To model physiological tissues in vitro with the same properties and
differentiation aspects as the in vivo situation, one must address the three dimensional
nature of native tissue, discussed in many other scenarios in this document. To account
for these differences, there must be a construct of three dimensions to which the cells can
attach, grow and proliferate in. Many methods of tissue engineering exist today for
approaches to 3D cellular growth, but none so far has stood out as the best for any
particular application, in pertinence to cell type, location in the native tissue, etc. Issues
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for choice of material for the constructs required by the application have yet to be
characterized fully, but the obvious credentials are easily identified. The material must
not be cytotoxic. It must harbor the cells, and promote growth and differentiation,
especially in the circumstance when one would choose a stem cell for the particular
application being studied.
Cellulose fibers are naturally occurring, abundant resource, and are present
already in many plants and bacteria. Cellulose also offers great promise in cell culture
and as a biomedical material, due to many factors including its biocompatibility. As
mentioned, it is already abundant in living things on earth, and is biocompatible with
human tissue, as well. The surfaces of cellulose fibers have reactive groups that can
manipulated for protein adsorption and binding. It is also attractive from an engineering
standpoint, in that its mechanical strength makes it a god choice for scaffolding, and its
resistance to hydrolysis would make it ideal for applications requiring permanent
structural support.
Cellulose is a glucose polymer with a bond structure that humans and most
animals do not possess the enzymatic capacity to degrade or digest. Buildup of large
quantities of cellulose would be detrimental, of course, but used as a platform for ex vivo
growth of tissue with subsequent re-implantation, the material has been shown to be safe
for use with granulation tissue and bone formation [117], [118]. It has also been shown
that this starting material can promote cardiac cell growth, while enhancing the
connectivity of the cardiac cells, thereby increasing the electrical functionality of the
excitable cells [119]. Cartilaginous tissue can exhibit enhanced development on cellulose
fiber scaffolds when the scaffold is pre-treated with calcium phosphate [120], and the
high density of reactive hydroxyl groups makes protein immobilization with fibronectin,
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and other cell adhesive proteins, a simple method for further enhancing cartilage growth
[121]. The densities of the glucan chain structures in the cellulose fibers impart the
necessary strength to support cell aggregates [122], and the fibers are very stable under
dynamic stress [123].
While the fibrillar structure provides good mechanical properties for tissue culture
applications, it does not naturally degrade in the body. If this is desired, the cellulose
material can be easily degraded with cellulase, an enzyme that digests cellulose. This
enzyme naturally occurs in termites, giving them the ability to digest wood fibers.
Similarly use of the enzyme would provide removal of the scaffold without harm to the
tissue-level organization resultant of the construct [122].
There is little research available demonstrating use of cellulose fibers as a 3D
scaffold, due to the lack of three dimensional architecture in its native form. Addition of
gelatin, a collagen derivative that is biodegradable, non-immunogenic, and inexpensive,
may add to the 3d characteristics of cellulose based tissue culture scaffolds. Collagen and
gelatin have been shown to have effective applications in tissue engineering scaffolds,
already [124], [125], [126]. By using these two methods in a combinatorial approach, the
goal was to synergistically increase the effectiveness of the resulting construct.
The ideal qualities of a scaffold material would include not only mechanical
strength, but a high porosity that would allow sufficient oxygen diffusion to sustain a
growing cell aggregate. Mechanical testing was also performed by the Lvov group to
elucidate the properties of the construct in comparison to the stated ideals. Mercury
porosity testing put the porosity of the 75% fiber/gelatin construct at approximately
seventy percent, with pores large enough for nutrient transport as well. These same
scaffolds showed a Young's modulus of roughly eight times the gelatin alone, indicating
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a much higher mechanical tensile strength, and exhibited four times the peak stress as the
gelatin alone.
The fluorescence images revealed a greater propensity for alignment of cells and
fibers in the fiber/gelatin construct than the gelatin alone. While the alignment aspect is
important, it is also worthy of note that both scaffold conditions were seeded with the
same number of cells, and appeared to have greater fluorescence in the gelatin alone,
suggesting better cell survival and proliferation with the human glioblastoma line CRL2020. It is also suggestive of a possible alteration to the approach, using less fiber and
more gelatin, as no other conditions were studied.
Despite the suggestion that there may be greater survival in the gelatin alone, cell
invasion to the inner portion of the matrix was confirmed with confocal microscopy.
Cells can grow throughout the construct, and are less clustered in the fiber/gelatin matrix
than gelatin alone; leading us to believe the fibers may provide better guidance to effect
cell growth. In the light of previous discussions about contact guidance, and surface
chemistry, along with topography, the assumption would seem to be supported.
Cellulosic materials have demonstrated good biocompatibility and mechanical
strength to be used as a biomedical engineering material. It has been shown that different
cellulosic materials can be used for bone [118], cardiac [119], and cartilage growth [120].
In the experimental scaffolds, the gelatin coating rendered the fiber surface suitable for
cell culture, as well as providing spacing for the cellulose fibers. The surface and
structure of scaffolds can significantly influence the interaction between scaffold and
cells as well as cell growth, migration and differentiation [124]. The rough structure of
cellulose fiber/gelatin scaffold may also play an important role to promote cell adhesion
and interaction with materials. It was reported that the interconnections between
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microfibers facilitate cells to cover the micro-fiber scaffold [127], and this work has
discussed the importance of micro- and nanotopography at length. In the cellulose
fiber/gelatin scaffold, the interconnection was not limited to between fibers, but also
included between gelatin film and fibers. In this way the scaffold may provide better
support and guidance to the cells.
The gelatin scaffolds tended to dissolve quickly in cell culture conditions, making
it impossible for us to remove the scaffold intact. However, MTT analysis did show that
for both scaffold types, cell viability/metabolism increased 5-fold by 17 DIV compared to
values at 2 DIV. This increase is not reflected in the chart, as all values are normalized to
the control for that time point, meaning the value of the control cells becomes one, with
the other treatment conditions a ratio of the raw value for that condition to the raw value
of the control at the time point.
The gelatin/cellulose fiber scaffold provided two important aspects for tissue
engineering: three dimensional structures within which cells could grow, and sufficient
porosity and liquid uptake so that cell culture media containing nutrients could penetrate
into the matrix. At the microscopic level, cellulose fibers within the gelatin matrix also
appear to provide sufficient pattern structure to allow for some alignment of cells. In fact,
the fibers were chosen in part due to their intrinsic width, sufficient to allow for single
cell alignment, such as is shown in. Cell alignment is beneficial for neural tissue
engineering where cellular orientation is important. Additionally, cell alignment may
influence the cell morphology, cytoskeleton organization and differentiation, which has
been suggested many times in this work.
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4.3 Non-Adhesive Cell Culture Surface Fabrication
4.3.1 Non Adhesive Surfaces in Conjunction with Patterned
Adhesive Areas for Cell Culture
4.3.1.1 BSA Blocking and Polymer Non-Adhesive Coating
The NeN system offers quick, precise patterning that is simple to reproduce, and
is flexible to the needs of the project. The surfaces patterned on are readily available
cover slips, or other suitable surfaces for tissue culture. With glass, the method of linking
the biological liquids to the glass surface was silanization of the cover slips. While our
group achieved levels of success, our patterns had been limited in size, and the cell
densities required to seed small patterns and maintain fidelity in binding were very low.
Hence, a blocking agent was sought that would perform at a level higher than the bovine
serum albumin (BSA) in use. The patterns look like that in Figure 39.

Figure 39. FITC conjugated Poly-L-lysine patterned on
APTES coated glass cover slip.
Once the pattern is applied to the cover slip, then an agent to block non-specific
binding is applied over the entire surface. As the results were good with BSA for small
areas, we wanted to increase pattern size and complexity, which would require higher
density and larger volumes of cells for seeding. Experiments showed we would need
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better blocking of the non-binding area. Patterned cells seeded at lower densities, such as
referenced earlier, can be seen follow the patterns during growth for the first two to four
days of growth, after which, the non specific blocking seems to deteriorate. Successful
patterning with PLL is shown at 200x magnification in Figure 40, at two days on the
pattern, the astrocytes shown are expanding away from the pattern. These results led to
questioning the suitability of BSA blocking for more complex designs that would require
more time for the cells to grow, or higher seeding densities, as previously mentioned.

Figure 40. Astrocytes on PLL pattern. Left panel is
fluorescent image while right panel is phase contrast
through the filter set for fluorescence, giving it green tinge.
The search for a blocking agent led to polymer chemistry, and an inexpensive
block copolymer was brought in to experiment with. The initial cytotoxicity experiments
involved simply putting the dissolved polymer on small spots on polystyrene tissue
culture ware. The spots were removed and rinsed with water. When cells were added, it
was realized immediately that there was potential in this treatment. Figure 41 shows the
first results in an interesting image that is a mosaic of twenty separate images of CRL
2303 cells seeded in a dish with the circular outline treated with only a few microliters of
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the polymer solution. These images were captured at 1 OOx magnification and stitched
together with Photoshop® to create on large image.

Figure 41. Large mosaic image showing high level of cell
exclusion from treated area, even at 2 DIV despite high
seeding density of CRL 2303 brain cancer cells
This was the point where research on the patterning aspect shifted to more of the
capabilities of the polymer.
4.3.2 Polymer Treatment on Large Scale for 3D Tissue
Cultures
4.3.2.1 Initial Results of Large Scale Treatment
As discussed earlier, most tissue culture polystyrene is treated to make the surface
more amenable to cell culture. This treatment allowed the glioma cells to adhere after
only a few days. Astrocytes seeded on the polymer were not as quick to adhere, but
would nonetheless adhere, if left long enough. Untreated tissue culture polystyrene was
used with markedly improved results. Astrocytes grown in the untreated dishes adhered,
but assumed a spindly, highly polarized shape instead of their normal morphology. CRL2303 cells were slightly thinner to the eye, as well. The most noticeable difference was
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that the coating now lasted longer, and there was little encroachment of the cells into the
treated area. Astrocytes are shown in Figure 42 at IDIV, and in the control group with no
treatment are spread all over the plate, while the treated circle showed exclusion.

Figure 42. Astrocytes on treated circle, left. The right panel
is untreated control.
The glioma cells showed similar responses, with heavy seeding, showing little to
no encroachment on the treated areas, as seen in Figure 43 at 1 DIV. Heavy seeding of
glioma cells would usually lead to confluent monolayers of cells.
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Figure 43. Glioma cells treated circle and un-treated circle
side by side.
The coating remains cytophobic for many days, with minimal invasion of even
the aggressive CRL-2303 line. The results were promising and suggested additional uses
for the coating. Once it was established that the inhibition of cell adhesion persisted for
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days, based on the seeding density, as Figure 44 shows after 2DIV, the choice was made
to pursue larger scale experiments with the coating.

Figure 44. CRL 2303 at 2DIV with no encroachment on
treated surface.
The next discovery was that if the entire surface was coated, then protein
adsorption and call adhesion dwindled to almost nil, as brain cancer cultures were
maintained for over a month in non-tissue-culture-treated, polymer coated dishes. Further
experiments were done that led to the filing of a report of invention to the university.
Those experiments will be discussed in the next section.
4.3.2.2 Neurospheres, Cytophobic Surfaces, and
Tumorgenesis
This brings the discussion to cytophobic coatings. With the primary cells derived
from neonatal rats bread at the Louisiana Tech University Biomedical Engineering
animal handling facility, this tissue source was used to produce large quantities of

neurospheres via the cytophobic coating. As shown in Figure 45, the spheres are large
and contain a large number of neural stem cells.

Figure 45. Confocal slice of hollow neurosphere stained
with calcein A.M.
The application of the polymer coating in respect to the glioma cell line became
interesting, as well. There are reports of gliomas forming neurosphere like structures,
which normally adherent cell lines are not supposed to do. Once grown in vessels treated
with the polymer coating for non-adherence, the CRL-2303 cells began to reproduce
rapidly, in a non-adherent spherical culture. This type of 3D culture is not unlike the
natural progression of tumors in vivo. With the cells free to grow in all dimensions, the
colonies will continue growing until they become diffusion limited, and necrotic areas
can be seen within the sphere. This progression is similar to tumors in the body that do
not possess the factors required for angiogenesis. The non-angiogenic tumors have what
is called a low "proliferating fraction." The progression of these CRL-2303 cells is
startling, and can be seen in a 7 day montage in Figure 46. Their ability to grow
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Figure 46. CRL 2303 tumor progression,

to over three times the original area in 7 days shows tremendous growth. The growth
calculated by image analysis software is in two dimensions, with the normalized growth
at over three hundred percent, as represented in Figure 47.
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This method of cancer cell growth can shed new light on cancer biology, as this
may be one of the first, if not the very first system to accurately model tumor progression
in vitro, in three dimensions. Computational biologists have long been rewriting code to
model tumor growth, and robust algorithms are available, but none are based on
laboratory results under fixed conditions, there are variations due to age, time of onset,
etc. that increase the variability of the data. This method has the capacity to be set for
high throughput, with high throughput image analysis as well.
Non-adherent tissue culture vessels are commercially available, as the interest in
stem cell technology is high. The need of such vessels arises in cancer research and stem
cell research. Cancer is known for its ability to continue to grow, and reproduce
inexorably, and this is a similar trait of stem cells, although stem cells only do so once
isolated from their native tissue. Otherwise, stem cells are quiescent, and await the call of
injury or disease before they set off on their reproduction and differentiation path.
Perhaps there are answers for each field in the other: cancer may hold the key to igniting
the natural healing power we already possess, and stem cells can show the way to turn off
the unruly cancer cells that will not cease growth.
4.3.2.3 Significance of Spheroid Modeling and
Neurosphere Cultures
Neural stem cells were only just identified in the nineteen nineties, making them a
relatively new realm of research. Neurospheres are also a relatively new area of research,
as they were only reported approximately ten years ago. Until the identification of a
neural stem cell, the prevailing belief was that after a certain point, neurons do not regenerate, and no new neurons are produced. Since no one ever saw a new neuron, they
did not exist. Since the discovery, and subsequent verification of the neural stem cells,
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there has been a great deal of interest in these types of cells. The regenerative medicine
field of course looks to stem cells to heal injuries and disease with various
administrations of stem cell technologies.
To demonstrate what stem cells may be capable of doing, a definition of a stem
cell is in order. The basic definition of the embryonic stem cell is an undifferentiated cell
capable of mitotic division through many cycles, to produce a clonal, or identical,
population of cells. This capacity is what separates stem cells from differentiated adult
cells. Due to some function of differentiation, the repeated replication of the cell leads it
farther and farther away from its original genetic signature. As mentioned, neural stem
cells are progenitor cells, as well, but they differentiate, only into neural cell types, such
as astrocytes, neurons, or microglia. Embryonic stem cells are labeled as "pluripotent," as
they may differentiate into any type of tissue, depending upon the stimulus. With limited
differentiation the neural stem cells are only "multipotent."
With this ability to differentiate into any type of neural tissue, the neural stem cell
is targeted as a "magic bullet" to fix all the mental ailments. Stem cell treatments have
been proposed to treat depression, seizures, Parkinson's disease, and many others. This
clinical application requires robust protocols for cell handling and use. A reliable way to
produce these cells is needed. Currently, there have been reports of teams around the
country that have been able to "reprogram" certain types of cell into a stem-cell like state,
where it can become more than one cell type. Reprogrammed, multipotent or pluripotent,
these are interesting cells from a biological standpoint. They are just as interesting in the
biomedical perspective, and generating stem cells could be beneficial to cell patterning
experiments. This is where stem cells and neurospheres merge. Sphere forming is a
phenomenon that only happens with neural tissue with a large amount of undifferentiated
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cells. As the animal matures, the production of neurospheres is less implying a level of
differentiation from which there is no return to stem-cell-like states.
With this portion of the research recently completed, a grant was won allowing
for LONI computing time, and a computational biologist to further the work started here.
The tumor spheroids and the novel polymeric coating that allows their growth will be
evaluated in much greater detail.

CHAPTER 5
CONCLUSIONS AND FUTURE W O R K
5.1 Conclusions
Throughout the various experiments of the three distinct, but related projects
examined here, the continuous thread has always been a question. "How can this apply to
an experimental setup and exhibit control of another facet of the cells in question?"
Apoptotic cues affect cell shape and growth rates. These cues are not easily applied to
individual cells or even whole cultures, as some of the other aspects of controlling cell
growth and morphology.
Glutamate was shown to delay the caspase-3 response to staurosporine stimulus,
and this effect can be used to modulate apoptosis. Future exploration seems warranted.
The scaffold material was biocompatible, and showed excellent long term cellular
activity, as indicated the MTT data. This behavior suggests the scaffolding should be
evaluated further.
The cytophobic cell surface coating can be used as part of a multifaceted
bionanocomposite approach to cellular architecture. Applications for this coating in
medicine, and biology can be pursued based on evidence discussed here. There is also the
aspect of the stem cell biology that this coating can induce, simply by growing cells in
non-adherent culture conditions, which would lend itself well to ensuing research. As
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Figure 48 shows, there are many factors within the bounds of this dissertation that could
still be explored.

Overarching Goals of Tissue Engineering

<S=3

Affect cell position, function IB space and time
\ f l e c t ARCHITECTURE

ctfceB cultures

E x e r t control at t o e cellular le-v el t o s h a p e tissues

Figure 48. Applications of results discussed throughout this
dissertation to future avenues of enquiry.
All of these aspects have brought a fuller understanding of the complexities that
govern life at the cellular level, while many questions remain to be explored.
5.2 Future Work
These projects all hold great promise for future work. There is room to continue
working with Dr. DeCoster on many ideas for multiplexing all of the levels of control
exhibited here. There are LbL approaches that can add nuances to the fiber/gel structure,
along with localized hydrophobic coatings, and adsorbed protein growth factors that
could be used to stimulate growth without being consumed and degraded, due to the
chemistry of the situation. There are soluble cytokines that would be interesting to pattern
using the NanoEnabler, a system that could be used to a much fuller extent.
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There exists a need for development of a beginner's level microscopy class, as the
Biomedical Engineering students here at Louisiana Tech University are by and large
unfamiliar with microscopy, and the resources here are phenomenal. By raising the
comfort level of the students with the equipment, and by encouraging them to spend
some quality time with the machines and the image processing software, the results, and
quality of work would increase. Just in helping with some of the other students, the
author has seen great improvements in the work of students who sought help. There was
also evidence of advanced theoretical planning of the work, when they begin to
understand how to use the microscopes.

APPENDIX A
MATERIALS AND METHODS
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A.l Locke's Solution
Reagents for 250 ml solution
•

2250 mg of sodium chloride (NaCl) (154 mM)

•

104.4 mg of potassium chloride (KC1) (5.6 mM)

•

75.6 mg of sodium bicarbonate (NaHC03) (3.6 mM)

•

84.5 mg of calcium chloride (CaCl2.2H20) (2.3 mM)

•

252.3 mg of glucose (5.6 mM)

•

1.25 ml of IM stock 4-(2-hydroxyethyl)-l-piperazineethanesulfonic

acid

(HEPES) (pH 7.4) (5 mM)
•

Water (Purified) 248.75 ml
Preparation of Locke's' solution
Add the components together in the following manner:

1.

Dissolve the components in 100 ml of purified water and add to the vacuum
filtration unit.

2.

Add 100 ml of purified water to the vacuum filtration unit.

3.

Add water with dissolved components.

4.

Add 1.25 ml of 1M stock Hepes.

5.

Add remaining amount of purified water.

6.

Place cap on unit. Carefully turn on the vacuum.

7.

Allow all the liquid to pass through the filter. Turn off the vacuum before bubbles
form.

8.
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9.

Twist the top of the vacuum unit off carefully. Screw the sterile cap onto the
container of the media.

10.

Label as Locke's' solution with date and lab name. Store in refrigerator at 4 °C.
A.2 Thawing and Culturing of Cells

Thawing cells
1.

Remove vial of cells from liquid nitrogen and place in water bath preheated to 37
°C.

2.

Thaw the vial containing the cells (approximately 5 minutes).

3.

Remove the vial, and wipe the vial with ethanol and kim wipe under laminar
hood.

4.

Gently transfer the cell suspension into 15 ml centrifuge tube and add 6 ml of
prewarmed rat brain endothelial cell growth medium drop wise onto the cells.

5.

Mix the cell suspension by aspirating using a pipette and transfer the cell
suspension to appropriate flask coated with attachment factor solution.

6.

Label the flask with cell type, date and passage number.

7.

Incubate cells for 24 hours at 37 °C in 5% C0 2 incubator.

8.

Remove media from cells to remove traces of dimethylsulfoxide (DMSO) and add
fresh, pre-warmed cell culture media.
Feeding cells

1.

Remove 3 ml of media from 25 cm flask into a waste beaker.

2.

Add 3 ml of prewarmed cell culture media to the cells.
Label the flask with the date of feeding.
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A.3 Isolation ofprimary rat brain cortical cells
1.

Put a pair of gloves on.

2.

Place 8-10 ml basal media in centered dish with transfer pipette.

3.

Place 10 ml basal media in 50 ml centrifuge tube in the holder and recap.

4.

Remove one pup from the box by pinching the skin above the spine near the
lower back and set on a paper towel.

5.

Spray the rat (pup) with alcohol and pick the pup up once more by the pinching
method.

6.

Quickly set cervical scissors behind the ear being cautious of the paws. Once the
pup straightens its neck, make one very quick and decisive cut. Dip scissors in
alcohol container without utensils and place scissors on a clean paper towel.

7.

Blot head at point of disarticulation on paper towel and wash the entire surface
with alcohol. Place body in the discard dish.

8.

Pinch the skin underneath the head by its neck. Place micro-scissors underneath
the skin at the top middle of the head at the disarticulation point. Cut the skin by
pulling it up and away from the surface. Dip the scissors in alcohol to clean.

9.

This should expose the skull (transparent appearance). While using the microscissors, cut the skull with the same motion as the skin. Dip scissors in alcohol to
clean and place on diaper with cervical scissors.

10.

The skull should separate. With the large forceps, curl back both sides of the skull
to expose the brain. Dip forceps in alcohol to clean.

11.

Locate olfactory bulbs and place the small spatula between the bulbs and the
brain. Scoop the brain out and into the basal media. Dip the spatula in alcohol to
clean.
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12.

Take the spatula and remove the cerebellum at the demarcation line and place the
cerebellum in the discard dish. Dip the spatula in alcohol to clean and place on
diaper.

13.

Pierce the brain with the large forceps (to keep in place) and begin removing
meninges and blood vessels with the small tip forceps. Discard waste to discard
dish. Remember to turn brain to remove meninges and blood vessels from both
sides.

14.

Once the blood vessels and meninges are removed, uncap 50 ml tube containing
basal media and place all brain tissue into the media. Recap.

15.

Remove brain tissue from the 50 ml pipette by aspirating with 10 ml pipette and a
pipette aid.

16.

Blow out tissue in the 15 ml tube.

17.

Add 8 ml complete media to the brain tissue and titrate with a 5 ml pipette.
Aspirate until the cells are suspended in the media.

18.

To let the brain tissue settle, place the 15 ml tube in large beaker of ice for 5
minutes.

19.

The supernatant will contain the neuronal cells. Remove the supernatant, place it
in a 15 ml tube, and place it on ice.

20.

Repeat step 19 twice.

21.

Centrifuge the neuronal cells in the three 15 ml tubes and follow the rat brain cell
culturing protocol as usual to count and plate cells.
A.4 Astrocyte New Media
For 250 ml total media, use the following amounts:
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•

12.5 ml Horse Serum (5.0%)

•

12.5 ml Fetal Bovine Serum (5.0%)

•

1.25 ml Penicillin/Streptomycin (0.5 %)

•

223.75 ml Ham's F-12K media with L-Glutamine
Add the components together in the following manner:

1. Add 100 ml of Ham's F-12K media to sterile vacuum filtration unit.
2. Add Horse Serum, Fetal Bovine Serum, and P/S to vacuum filtration unit.
3. Add 123.75 ml of Ham's F-12K media to unit.
4. Place cap on unit. Carefully turn on vacuum.
5. Allow all the liquid to pass through the filter. Turn off vacuum before bubbles
form.
6. Twist top of vacuum unit off carefully. Screw sterile cap onto container of media.
7. Label media as Astrocyte New Media with date and lab name. Store in
refrigerator.
A.5 CRL-2020 Cell Protocols
A.5.1 Thawing Cells:
1. Remove vial of cells from liquid nitrogen and immediately place in water bath
preheated to 37°C.
2. Thaw quickly (approx. 3 minutes).
3. Remove vial, wipe vial with ethanol and kimwipe under hood.
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4. Transfer the contents of the vial to a 75 cm2 flask containing pre-warmed CRL2020 medium. Gently mix contents of vial without creating bubbles and check
for pellet at bottom. Wash vial with warmed media. It is not necessary to remove
the cryoprotective agent from the cells.
5. Label flask with cell name, date, and passage number.
6. Incubate culture at 37°C in 5% C0 2 incubator.
A.5.2 Feeding Cells
1. Remove 10 ml media from 75 cm2 flask (5 ml from 25 cm2 flask) into a waste
beaker.
2. Add 10 ml pre-warmed CRL-2020 media (5 ml for 25 cm2 flask) to the cells.
3. Label flask with date of feeding.
A.5.3 Splitting Cells or Replating Cells
1. Remove media from cells into waste beaker.
2. Wash flask once with 10 ml lx PBS (1 ml 1 Ox PBS + 9 ml sterile water). Pipet
PBS gently into flask. Lay flask down once. Lift flask and remove PBS.
3. Add 6 ml thawed Trypsin/EDTA to flask. Cap the flask and gently shake to help
cells detach. This may take about 5 minutes. Check flask under microscope to
ensure cells are detaching.
4. Remove Trypsin/EDTA and cells from flask into 15 ml centrifuge tube. Wash
flask once with ~6ml cold CRL-2020 media. Remove CRL-2020 media from
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flask and add to centrifuge tube to deactivate Trypsin/EDTA. Important—Mix
tube by inversion (don't vortex) before Centrifuging.
5. Centrifuge cells in tube using a counterbalance in pre-cooled centrifuge (10°C) at
15Ox rcf for 7 minutes.
6. After spinning, remove supernatant liquid into waste beaker.
7. Resuspend pellet in desired amount of cold CRL-2020 media. (3 to 4 mLs
depending on size of pellet) Resuspend pellet from bottom of tube, then vortex
until cells are evenly distributed throughout media.
8. Optional: before plating count cells if needed, see cell counting protocol.
9. Plate cells onto new flasks or dishes, adding the appropriate amounts of cold
CRL-2020 media.
10. Label flasks and dishes with cell name, date, and passage number (passage
number increases when splitting cells).
A.5.4 Freezing Cells
1. Remove media from cells into waste beaker.
2. Wash flask once with 10 ml lx PBS (1 ml 1 Ox PBS + 9 ml sterile water). Pipet PBS
gently into flask. Lay flask down once. Lift flask and remove PBS.
3. Add 6 ml thawed Trypsin/EDTA to flask. Cap the flask and gently shake to help
cells detach. This may take about 5 minutes. Check flask under microscope to
ensure cells are detaching.

4. Remove Trypsin/EDTA and cells from flask into pre-cooled 15 ml centrifuge tube.
Wash flask once with ~6ml cold CRL-2020 media. Remove CRL-2020 media from
flask and add to centrifuge tube to deactivate Trypsin/EDTA.
5. Centrifuge cells in tube using a counterbalance in pre-cooled centrifuge (10°C) at
150x rcf for 7 minutes.
6. After spinning, remove supernatant liquid into waste beaker.
7. Resuspend pellet in desired amount of cold CRL-2020 media (1.3 ml if freezing
down entire flask to 1 cryovial). Remove pellet from bottom of tube, then vortex
until cells are evenly distributed throughout media.
8. Add 5% DMSO (70 ul fori cryovial to make 1.4 ml total volume) drop wise to cells.
Mix by inverting centrifuge tube.
9. Transfer cell mixture to pre-cooled cryovial.
10. Label cryovial with cell name, date, and passage number (passage number is same as
on flask).
11. Put cells on ice in refrigerator for 30 minutes.
12. Put cells in freezer for 30 minutes.
13. Put cells in -80°C freezer overnight.
14. Transfer cells into liquid nitrogen. Record cane number.
A.5.5 CRL-2020 Complete Media
a. For 250 ml total media, use the following amounts:

203.75 ml RPMI-1640 media
25.0 ml Fetal Bovine Serum (10%) (located in -80° freezer)
1.25 ml Penicillin/Streptomycin (200 fold dilution)
2.5 mg Adenine
0.25 mg ATP (located in -80° freezer)
8.75 mg Cystine (use IN NaOH, drop wise to aid dissolution. 40uL per
add,120uL

max)

891 mg HEPES
3.75 mg Hypoxanthine
7.5 mg Proline
0.25 mg Thymidine
Add the components together in the following manner:
Put 20 ml RPMI-1640 media in 2 15 ml centrifuge tubes (10 ml in each tube).
Add measured components to these tubes and mix until dissolved.
Add 100 ml of RPMI-1640 media to sterile vacuum filtration unit.
Add Fetal Bovine Serum, P/S, and 20 ml RPMI-1640 media containing
components to vacuum filtration unit.
Add 103.75 ml of RPMI-1640 media to unit.
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6. Place cap on unit. Carefully turn on vacuum.
7. Allow all the liquid to pass through the filter. Turn off vacuum before bubbles
form.
8. Twist top of vacuum unit off carefully. Screw sterile cap onto container of media.
9. Label media as CRL-2020 media with date and lab name. Store in refrigerator.
A.5.6 CRL-2303 Media
A.5.6.1 Media Components
221.3mL Delbecco's Modified Eagle's Medium (DMEM)
1.25mLPenn/Strep(PS)
25mL Fetal Bovine Serum (FBS)
2.5mL Amino Acid Solution
A.5.6.2 Making the Media
1. Add 110.65mL DMEM to filtration unit.
2. Add 1.25mL PS to filtration unit.
3. Add 25mL FBS to filtration unit.
4. Add 2.5mL Amino Acid Solution to filtration unit.
5. Add 110.65mL DMEM to filtration unit.
Connect sterile filtration tubing to filtration unit and vacuum nozzle.
-make sure to hold filtration unit while performing this task, so the unit
does not turn over
While holding unit slowly turn on vacuum to a medium drip.
Remove vacuum seal before media has been completely filtered.

A.6 DAPI Protocolfor Living Cells
Notes:
Stock solution labeled "D," located in -80°C freezer, 14.27 mM in DI water
Locke's located in 4°C fridge in IFM
Will be performing 2 dilutions:
First is a 1 to 100 dilution with your stock. Take 3 ul of your stock and dilute
with 297 ul of Locke's.
You will then use the dilution performed above and do another dilution, a 1 to 10
dilution. Most likely you will be adding this to a dish with 3 ml of media. Therefore a 1
to 10 dilution would be 300 ul from your first dilution in the 3 ml dish.
Once DAPI has been added place dish in 37°C incubator for 10 minutes
(depending on the health of the cells you may need a longer time to load do to the fact
that healthy cells take longer to load DAPI than damaged or dead cells).
A. 7 CRL 2570 (Jurkat T-cells) Media
A.7.1 Requirements
1) RPMI-1640
2) Fetal Bovine Serum: 25 ml.
3) Penicillin/Streptomycin: 1.25 ml.
A.7.2 Procedure
1) Adjust the filtration unit and add about 112.5 ml. of RPMI-1640 to it.
2) Then add about 25ml. of Fetal Bovine Serum (FBS) on it. (Thaw FBS in hot
water bath for 10-15 min.)
3) Add 1.25 ml. of Penicillin/Streptomycin solution on it.

4) Then again add 112.5ml. RPMI-1640 on it and start the air suction to filter
media.
5) After completing cap the media bottle and mark it as CRL 2570 media and
store at 2-8 °C.
A.7.3 Thawing
1. Pre-warm flask with media for 15 minutes in C0 2 incubator
2. Thaw cryo-vial, always clean the cryo vial with kim wipes and add cells to flask
3. No need to wash cryo-preservation medium
Subculturing:
1. Remove sufficient cells from plate or flask (example 8 mis from T75 flask)
2. Make sure to replace an equal amount of media (warm) to the plate or flask you
took from.
3. Centrifuge at 150 RCF (refrigerated) for 5 minutes to form pellet
4. Resuspend pellet and count if needed.
5. Plate resuspended cell on plate or flask and increase passage # by 1.
Note: These cells do not attach to the surface of the dish or the flask.
NOTE: Centrifugation after DMSO cryopreservation damages cells, therefore,
passaging after thawing should be done without centrifugation.
Later passaging may be accomplished with centrifugation.
A. 8 Lonza Astrocyte Protocols
A.8.1 Thawing Cells
6. Remove vial of cells from liquid nitrogen and immediately place in water bath
preheated to 37°C.
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7. Thaw quickly (approx. 3 minutes).
8. Remove vial, wipe vial with ethanol and kimwipe under hood.
9. Gently transfer 1 ml cells into 15 ml centrifuge tube and immediately add 6ml
pre-warmed AGM (Astrocyte Growth Media) dropwise onto cells. Takes
approx. 2 minutes.
10. Mix cell suspension by inverting the tube carefully twice. DO NOT VORTEX
CELLS.
11. Transfer cell suspension to appropriate flask or dish with pre-warmed AGM.
12. Label flask with cell type, date, and passage number (passage number increases
when thawing cells).
13. Incubate cells for 4 hours at 37°C in 5% C0 2 incubator.
14. Remove medium from cells; leave small volume so cells don't dry out. Add
fresh, pre-warmed AGM.
15. Every 4-5 days, change 50% of the media to fresh, pre-warmed AGM.
A.8.2 Feeding Cells:
1. Remove 10 ml media from 75 cm2 flask (5 ml from 25 cm2 flask) into a waste
beaker.
2. Add 10 ml pre-warmed AGM (5 ml for 25 cm2 flask) to the cells.
3. Label flask with date of feeding.
A.8.3 Splitting Cells:
4. Remove media from cells into waste beaker.
5. Wash flask once with 10 ml lx PBS (1 ml lOx PBS + 9 ml sterile water). Pipet
PBS gently into flask. Lay flask down once. Lift flask and remove PBS.
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6. Add 6 ml thawed Trypsin/EDTA to flask. Cap the flask and gently shake to help
cells detach. This may take about 5 minutes. Check flask under microscope to
ensure cells are detaching.
7. Remove Trypsin/EDTA and cells from flask into 15 ml centrifuge tube. Wash
flask once with ~6ml cold AGM. Remove AGM from flask and add to centrifuge
tube to deactivate Trypsin/EDTA.
8. Centrifuge cells in tube using a counterbalance in pre-cooled centrifuge (10°C) at
15 Ox rcf for 7 minutes.
9. After spinning, remove supernatant liquid into waste beaker.
10. Resuspend pellet in desired amount of cold AGM. Remove pellet from bottom of
tube, then vortex until cells are evenly distributed throughout media.
11. Plate cells onto new flasks or dishes, adding the appropriate amounts of cold
AGM.
12. Label flasks and dishes with cell name, date, and passage number (passage
number increases when splitting cells).
A.8.4 Freezing Cells:
1. Remove media from cells into waste beaker.
2. Wash flask once with 10 ml 1 x PBS (1 ml 1 Ox PBS + 9 ml sterile water). Pipet PBS
gently into flask. Lay flask down once. Lift flask and remove PBS.

3. Add 6 ml thawed Trypsin/EDTA to flask. Cap the flask and gently shake to help
cells detach. This may take about 5 minutes. Check flask under microscope to
ensure cells are detaching.
4. Remove Trypsin/EDTA and cells from flask into pre-cooled 15 ml centrifuge tube.
Wash flask once with ~6ml cold AGM. Remove AGM from flask and add to
centrifuge tube to deactivate Trypsin/EDTA.
5. Centrifuge cells in tube using a counterbalance in pre-cooled centrifuge (10°C) at
150x rcf for 7 minutes.
6. After spinning, remove supernatant liquid into waste beaker.
7. Resuspend pellet in desired amount of cold AGM (1.3 ml if freezing down entire
flask to 1 cryovial). Remove pellet from bottom of tube, then vortex until cells are
evenly distributed throughout media.
8. Add 5% DMSO (70 ul fori cryovial to make 1.4 ml total volume) drop wise to cells.
Mix by inverting centrifuge tube.
9. Transfer cell mixture to pre-cooled cryovial.
10. Label cryovial with cell name, date, and passage number (passage number is same as
on flask).
11. Put cells on ice in refrigerator for 30 minutes.
12. Put cells in freezer for 30 minutes.
13. Put cells in -80°C freezer overnight.
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14. Transfer cells into liquid nitrogen. Record cane number.
A.8.5 Lonza Astrocyte Growth Media
ALL components must be sterile. Do NOT sterile filter using vacuum
filtration.
For 500 ml total media, use the following amounts:
•

15 ml Fetal Bovine Serum

•

0.5 ml Ascorbic Acid

•

0.5 ml G/A-1000

•

1.25 ml Insulin

•

5.0 ml L-Glutamine

•

477.75 ml Astrocyte Basal Medium (ABM)
Add the components together in the following manner:

1. Add the components to the bottle of ABM.
2. Mix using 25 ml pipet. Don't invert because it could compromise sterility.
3. Label bottle as AGM with date and lab name. Store in refrigerator.
A.9 MTT Assay (Jurkat-CRL 2570)
Procedure for a 24 well plate
It takes 400uL of a solution to completely cover the bottom of a well in a 24 well
plate. This being considered, 9.6mL of MTT would be needed to treat an entire plate.
1 lmL will be prepared to allow a safety buffer volume.
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1. Dilute MTT to 5.0mg/mL in Locke's solution then follow a 4x dilution for a final
concentration of 1.25mg/mL for this 13.75mg of MTT powder needs to be added
to 1 lmL of Locke's solution.
2. Media is removed from cells. Do not wash.
3. Centrifuge (at 200 RCF for 7 minutes) the cells to form pellet, remove the
supernatant, discard then add 400uL of MTT solution to each tube (Make sure the
MTT solution is warm).
4. Let MTT incubate for at least one hour. In viable cells the yellow solution will
yield blue crystals.
5. After 1 hour remove the MTT and cells together, put in Eppendorf tubes spin at
200 RCF for 9 minutes. At this point remove supernatant and discard.
6. Add 250uL of 91 % Isopropanol to the pellet and mix.
7. Transfer 200uL of the Isopropanol with dissolved crystals into wells of a 96 well
plate. Dispose of the remaining liquid.
8. Cells should be covered with 400uL of PBS to preserve them.
9. Measure the plate reader to a wavelength of 570.
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